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Abstract 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University. 
John Joseph Ryan 
Virginia Commonwealth University 
Advisor: Thomas F. Huff,Ph.D. 
Stem cell factor (SCF) is a recently characterized hematopoietic growth factor 
capable of stimulating the proliferation and differentiation of many hematopoietic 
cells, including the mast cell. We have cloned the gene encoding SCF from a eDNA 
library prepared from NIH 3T3 fibroblasts, and have characterized the ability of 
recombinant SCF to induce the development of mast cell-committed progenitors 
(MCCP), found in the mesenteric lymph nodes of mice infected with Nippostrongylus 
brasiliensis {Nb-MLN), but not naive mice. We have also examined Schwann cells, 
mast cells, and reproductive tissues for their ability to produce SCF. 
We have found that recombinant SCF alone can promote the formation of 
mast cell colonies from MCCP in methylcellulose. SCF affected not only MCCP 
proliferation, but could also induce their differentiation to connective tissue 
X 
phenotype mast cells. SCF was also capable of generating mast cell colonies from 
precursors found in the peritoneal cavity of naive mice. Unexpectedly, infection of 
mice with Nippostrongylus caused a loss of the precursors from the peritoneal cavity 
by 14 days after infection. 
Mast cells are found near Schwann cells, and increases in mast cells have been 
noted concomitant with Schwann cell neoplasia, and nerve damage and repair. 
Schwann cells from several sources were shown to produce mRNA for SCF, and the 
protein was also detected on the cell surface by immunofluorescent staining, or as a 
secretable product in cell-conditioned supernatant. Schwann cells were also analyzed 
for the ability to produce the receptor for SCF, c-kit. Immunofluorescent staining 
and polymerase chain reaction (PCR) analysis has shown that a human malignant 
schwannoma expresses c-kit, while normal human Schwann cells as well as SV-40 
transfected, primary neonatal and primary adult rat Schwann cells do not. Thus 
normal production of SCF could form an autocrine growth loop in some Schwann 
cell neoplasias which aberrantly express c-kit. 
Lastly, rat and human reproductive tissues were examined for expression of 
the SCF gene, using PCR and northern analysis. We found that SCF is expressed in 
a differential manner by various maternal and fetal tissues during pregnancy and the 
menstrual cycle. While rat tissues contained easily detectable SCF mRNA, human 
tissues appeared to express this gene in a lower quantity. 
Introduction 
Greater than 1 in 5 United States citizens suffers from some form of allergic 
disease (Bernstein and Lawrence, 1990), and many of these clinical phenomena have 
an associated mast cell hyperplasia. These include active inflammation, scleroderma, 
rheumatoid arthritis, keloid formation, neurofibromata, dense fibrosis, peripheral 
neuropathies, and posttraumatic nerve damage. Mast cell degranulation is also 
known to play an important role in asthma, allergic rhinitis, and atopic dermatitis. 
Furthermore, the proposed role of heparin in bone resorption implies a role for mast 
cells in rheumatoid arthritis, renal osteodystrophy, and postmenopausal osteoporosis. 
Treatment for these diseases often involves the use of drugs which affect mast cell 
function, such as antihistamines, corticosteroids, 8-adrenoreceptor agonists, and mast 
cell stabilizing drugs. Leukotriene antagonists are now being tested. 
The mast cell is an excellent system for the study of cell differentiation, since 
the signals required for development are relatively few, and the changes that occur 
are both unique and large scale. Mast cells develop prominent cytoplasmic granules 
containing histamine, polysulfated proteoglycans, and unique neutral proteases. 
Jarboe and Huff have described a late stage, non-granulated mast cell-committed 
progenitor (MCCP) present in the mesenteric lymph node of mice infected with 
Nippostrongylus brasiliensis (Nb-MLN), but not naive MLN (Jarboe et al., 1989). This 
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progenitor could be stimulated by fibroblast-conditioned medium to develop mast cell 
colonies in methylcellulose in the absence of IL-3, and the factor present in this 
conditioned medium was deemed to be novel. 
A recently cloned hematopoietic growth factor, stem cell factor (SCF), has 
been shown to induce mast cell development, function, and migration (Williams et 
al., 1990; Zsebo et al., 1990; Jozaki et al., 1991; Bischoff and Dahinden, 1992; 
Nakajima et al., 1992; Wershil et al., 1992). SCF is the ligand for the c-kit proto­
oncogene product, a receptor tyrosine kinase, and was shown to be produced by 
Buffalo rat liver cells, a human fibrosarcoma cell line, and NIH 3T3 fibroblasts in 
either a membrane-bound or secretable form (Flanagan and Leder, 1990; Williams 
et al., 1990; Huang et al., 1990; Zsebo et al., 1990). However, its activities are not 
limited to mast cells, as SCF can induce the proliferation and/or development of 
murine CFU-S, erythrocytes, lymphocytes, megakaryocytes, melanocytes, and germ 
cells (reviewed in (Williams et al., 1992), and is expressed in the nervous system 
(Keshet et al., 199 1). This wide range of activities described for SCF has made it a 
focal point in the study of hematopoiesis and the development of melanocytes, germ 
cells, and the nervous system. Since its identification in October, 1990, over 200 
publications have shown SCF to play an important role in many forms of cell 
development. 
We were interested in the ability of SCF to induce mast cell proliferation and 
differentiation from MCCP, and have sought to determine if SCF could substitute for 
fibroblast-conditioned medium. The availability of a recombinant molecule for 
studies of mast cell development using the MCCP would allow direct insight into the 
regulation of gene transcription during differentiation. 
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Mast cells have also been shown to reside in perineurial and epineurial spaces 
of peripheral nerves (Bienenstock et al., 199 1 ), often in close proximity to the 
Schwann cells which myelinate these nerves (Isaacson, 1976). Moreover, mast cells 
increase dramatically in peripheral nerve injury and repair (Isaacson, 1976), and in 
Schwann cell neoplasias such as the lesions of neurofibromatosis (Isaacson, 1976; 
Riccardi, 1981). The origin and role of mast cells in these phenomena is poorly 
characterized. The localization of SCF transcripts in the nervous system during 
murine embryogenesis (Keshet et al., 1991), and the known role of SCF in mast cell 
development implied that this growth factor may be produced by neuron-associated 
cells, such as Schwann cells. We have examined normal, transformed, and malignant 
Schwann cells from rat and human sources for their ability to produce SCF and its 
receptor, c-kit. Since SCF and c-kit have also been shown to influence germ cell 
migration and development (Keshet et al., 199 1 ;  Horie et al., 1 99 1; Manova et al., 
1990; Sorrentino et al., 1991), we have also examined maternal and fetal tissues 
during embryogenesis in the rat and human. 
Literature Review 
I) The Mast Cell 
The mast cell was first described in 1878 by Paul Ehrlich (Ehrlich, 1878), who 
named these granular, metachromatic cells from the German word mastung, meaning 
"to chew or masticate". Ehrlich thought the cells, which he obtained from frog 
mesentery, were overfed. Unna noted the increased presence of mast cells in 
urticaria pigrnentosa skin lesions (reviewed in (Michels, 1 938), and later these cells 
were shown to contain large amounts of histamine and heparin in their cytoplasmic 
granules. Wilander demonstrated the discharge of mast cell granules in 1939 
(Reviewed in(Bemstein and Lawrence, 1990), and Riley and West showed a 
correlation between mast cells numbers in tissue and histamine content (Riley and 
West, 1953). The metachromatic staining of these cells was also determined to be 
due to the presence of heparin in their cytoplasmic granules. 
However, research in mast cells made even greater strides in the 1 960's. Mast 
cells were shown to degranulate with specific antigen after sensitization ( Mota,I, et 
al., 1 960), and the Ishizakas identified and characterized the sensitizing antibody as 
IgE (Ishizaka, K, et al., 1966). The Ishizakas also demonstrated the presence of high 
affinity receptors for IgE (FcERI) on the surface of mast cells and basophils, and its 
role in antigen-induced degranulation (Ishizaka, 1972) ). In the same decade, 
Enerbach showed that two phenotypes of mast cells, connective tissue and mucosal, 
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existed (Enerback, 1 966). 
Mast cells are ovoid or irregular shaped, with a diameter of 9- 12 �-tm and a 
large oval nucleus. Mast cell granules are easily apparent in the cytoplasm, with a 
diameter of 0.2-0.4 �-tm. Unlike other hematopoietic cells, mature mast cells are only 
found in tissues, often at sites of internal-external boundaries such as the nasal and 
bowel mucosa, alveolar wall, conjunctiva, dermis and around blood vessels (Schwartz 
and Huff, 1992). Although the mast cell was originally thought to be related to the 
basophil, which was also described by Ehrlich (Ehrlich, 1879), we now know that 
there are important differences between these two cells and that they have separate 
lineages (Schwartz and Huff, 1992). Both basophils and mast cells express FcERI, are 
metachromatic and contain histamine. However, while basophils are terminally 
differentiated, polymorphonuclear and can invade tissues or circulate in the blood, 
mast cells are capable of proliferation, are mononuclear, and are found exclusively 
in tissues. Furthermore, mast cells express neutral proteases and the cis-acting DNA 
binding proteins GATA- 1,-2, and -3, which are not found in basophils (Martin and 
Orkin, 1990; Zoo et al., 199 1 ). Thus it is apparent that mast cells share some 
functional and staining characteristics with basophils, but the two cells are in fact 
quite different in their location and granule contents, and appear to be derived from 
separate progenitors. 
Mast cell degranulation releases potent inflammatory mediators in a complex 
process that can be induced by many stimuli. The process can occur through cross 
linking of FcERI molecules on the cell surface, which activates phospholipase C, 
leading to the generation of inositol triphosphate and diacylglycerol. The combined 
effort of these compounds results in the mobilization of cytosolic and extracellular 
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calcium, and the activation of protein kinase C (PKC). The action of PKC ultimately 
results in the formation of the fusogens lysophosphatidic acid and 
lysophophatidylcholine, which allow granules to be released from the cell (Schwartz 
and Huff, 1991).  Also, the initial activation of phospholipase C results in protein 
kinase A activation, which is important in histamine release. The breakdown of 
diacylglycerol leads to formation of arachidonic acid metabolites, which cause smooth 
muscle contraction, neutrophil chemotaxis, and mucus secretion (Bernstein and 
Lawrence, 1990; Katz et al., 199 1 ). This cross linking of FcERI molecules induces 
mast cell proliferation as well (Ashman et al., 199 1; Plaut et al., 1989). Alternatively, 
mast cell degranulation can be induced through the action of many agents other than 
IgE immune complexes. These include IgG immune complexes, the complement 
components C3a and C5a, calcium ionophores, polylysine, polyarginine, compound 
48/80, morphine sulfate, neuropeptides such as substance P, f-met peptides, and 
mellitin (Schwartz and Huff, 199 1). 
Minutes after degranulation, pruritis and urticaria occur, and a well­
documented "wheal and flare" reaction appears. A late phase of these reactions also 
takes place 3 to 12 hours after the immediate phase. This phase is characterized by 
less edema but more pain than occurs in the immediate reaction and an influx of 
activated eosinophils (Plaut et al., 1989). 
Mast cell mediators can be characterized into three classes: preformed, 
granule-derived mediators, membrane lipid-derived mediators, and cytokines (Katz 
et al., 199 1 ). The preformed mediators found in mast cell granules are the biogenic 
arnines histamine and serotonin, serine proteases such as chymase, tryptase, and 
carboxypeptidase A, acid hydrolases (Katz et al., 1991 ), and the proteoglycans 
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heparin and chondroitin sulfate. Histamine and serotonin induce vasodilation and 
spasmogenic reactions of smooth muscle, and can result swelling, pruritis, or difficulty 
breathing. The function of the neutral proteases is less well understood. Chymase 
is known to induce serous cell secretion, while tryptase enhances histamine-induced 
smooth muscle contraction. Carboxypeptidase A and acid hydrolases are degradative 
enzymes that can induce connective tissue damage. Heparin slows coagulation, and 
it and other proteoglycans can act as immunomodulatory agents. 
Mast cell membrane lipid-derived mediators are also important in the 
inflammatory process. Leukotriene (LT) B4 induces neutrophil chemotaxis, while 
LTC4 causes smooth muscle contraction, as does prostaglandin (PG) 02 (Katz et al., 
1 99 1 ). Platelet activating factor causes platelet and neutrophil activation. 
Cytokine production by mast cells is a recent discovery (Plaut et al., 1989; 
Gordon et al., 1990), and has served to further the known role of mast cells in 
inflammation. IgE cross linking was shown to induce the production of the 
interleukins (IL) IL-1 ,  IL-3, IL-4, Ilr5, and Ilr6, as well as granulocyte-macrophage 
colony stimulating factor (GM-CSF), interferon (IFN) gamma, transforming growth 
factor (TGF) 8, and tumor necrosis factor (TNF) ex (Katz et al., 199 1 ). This set of 
lymphokines resembles those produced by the T H2 subset of T lymphocytes (Plaut et 
al., 1989). Furthermore, these lymphokines are well suited for a role in allergic 
responses: IL- l induces lymphocyte activation; IL-3 is important in stem cell and 
mast cell development; Ilr4 induces IgE production and mast cell maturation; IL-5 
enhances eosinophil differentiation; and IL-6 plays an important role in B cell 
development (Katz et al., 199 1 ). Furthermore, GM-CSF induces myeloid cell 
development, and TNFa induces neutrophil chemotaxis (Katz et al., 1991). Taken 
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together, these cytokines enhance the production and differentiation of cells 
important in the allergic response, while inducing production of IgE antibody, and 
induce the chemotaxis of cells with a known role in inflammation. 
Mast cells were shown to develop from bone marrow stem cells in a complex 
series of experiments using the mast cell deficient mice WBB6F1-W /W. These mice 
were shown to be repopulated with mast cells after transplantation with normal 
syngeneic or semi-syngeneic bone marrow (Galli, 1990). It is now understood that 
mast cells leave the bone marrow in an immature form and migrate through the 
blood to mucosal and connective tissues, where they complete their differentiation. 
The signals that instruct mast cell development are not fully understood, but are 
known to involve IL-3, IIA, and the recently described product of the mouse Steel 
(Sl) locus, stem cell factor (SCF) ((Schwartz and Huff, 1992). While mouse mast 
cells can be derived from cultures of bone marrow grown with IL-3 alone, human 
mast cells do not express IL-3 receptors, and may rely solely on SCF for their 
development (Schwartz and Huff, 1992). The lineage that gives rise to mast cells has 
not been fully characterized, but will be discussed below. 
Ginsburg suggested that there were two subsets of mast cells, T cell dependent 
and T cell independent (Kishimoto et al., 1979). These are now known by a variety 
of names: IL-3 dependent and IL-3 independent, as called mucosal (MMC) and 
connective tissue (CTMC) mast cells in the mouse, and MC and MeTe in the human 
(Schwartz and Huff, 1992). Although there are some interspecies differences, the 
murine MMC and CTMC share many features with the human MCT and MCTc, 
respectively (Schwartz and Huff, 1991) .  
The two phenotypes of mast cells differ in their size, life span, staining 
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characteristics, and granule contents. MMC stain with aldan blue but not safranin, 
are smaller, have fewer granules and less histamine than CfMC, produce chondroitin 
sulfate E proteoglycan, and LTC4, and have a life span of about six weeks that is 
dependent upon IL-3 stimulation. MMC mast cells also express the mouse mast cell 
proteases (MMCP) 1, 2, and 4 (Gurish et al., 1992; Reynolds et al., 1990). By 
comparison, CTMC stain with aldan blue and safranin, are larger, have more 
granules and more histamine, produce heparin proteoglycan and PGD2, and have a 
life span of at least six months in the absence of IL-3 stimulation. CTMC express 
MMCP-3, 4, 5, and 6 (Gurish et al., 1992; Reynolds et al., 1990). Mouse CTMC are 
also sensitive to compound 48/80 and other non-IgE stimuli to which MMC do not 
respond. While MMC are found in the lamina propria, crypts, and between columnar 
epithelial cells, CTMC are located in dermis, in fibrous capsules of many organs, and 
in peritoneal fluid. Human mast cells are less well understood. The most noted 
difference in human mast cell subsets is the expression of the serine protease 
chymase (Schwartz and Huff, 199 1). While all human mast cells appear to express 
tryptase, chyrnase is expressed by mast cells found in greatest numbers in skin and 
intestinal submucosa, while those that express only tryptase are located primarily in 
the lung and intestinal mucosa (Irani et al., 1987). While there do not appear to 
large differences in histamine content, heparin synthesis, or arachidonic acid 
metabolites, MeTe cells respond to compound 48/80, while MCT cells cannot, 
mimicking the responses of CTMC and MMC, respectively. Also, immunodeficient 
patients who lack IL-3 have been shown to lack MCT, and have normal MeTe (Irani 
et al., 1987). Thus while there are differences between species, it is thought that 
MCT are similar to MMC, while MeTe resemble CTMC. In the murine system it is 
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apparent that both MMC and CfMC are derived from a common bone marrow 
progenitor, since normal bone marrow injected into W /W" mice gives rise to both 
phenotypes, and culture-derived mast cells can also give rise to MMC or CfMC 
(Kanakura et al., 1988). Some data suggest that Phenotypic changes can occur 
bidirectionally multiple times, and appear to depend upon the microenvironment in 
which the mast cells are placed (Kanakura et al., 1988). 
II) Nippostrongylus brasiliensis Infection and the Generation of Mast Cell­
Committed Progenitors 
It bas long been known that infection of mice with the rodent hookworm 
Nippostrongylus brasiliensis (Nb) results in a mucosal mastocytosis and concomitant 
increase in IgE production (Befus and Bienenstock, 1984). Therefore this infection 
has been used to study the roles and development of mast cells. Subcutaneous 
injection of the third larval form of Nb into mice or rats is followed by migration of 
the larvae to the lungs within 15 hours, where they molt to the fourth stage and 
migrate to the small intestines via the trachea and esophagus by day 3 (Ogilvie and 
Jones, 197 1 ). Here the larvae molt once more to the fifth, or adult stage. The 
worms reach a length of 2-6mm, and begin to produce eggs by day 6 (Ogilvie and 
Jones, 1971) .  Only about 55% of the worms injected reach maturity, but each adult 
female worm can produce up to 1000 eggs a day for a period of about six days, at 
which time the worms are usually expelled from the intestines (Ogilvie and Jones, 
1 97 1 ). The worms remain in the jejunum until expulsion, and although anemia is 
common during infection, they do not suck blood from their host (Ogilvie and Jones, 
1 97 1) .  The immune response to Nb infection results in an influx of leukocytes to the 
mesenteric lymph node. These include plasma cells, lymphocytes, mononuclear cells, 
1 1  
macrophages, eosinophils, and a notable mastocytosis (Ogilvie and Jones, 197 1 ). 
Bone marrow progenitors are known to traffic to the mesenteric lymph node 
(MLN) during infection with Nb (Ashman et al., 1991 ), and the mast cell hyperplasia 
coincident with infection is thought to be the result of both progenitor trafficking and 
local proliferation (Keller et al., 1974). However, while mast cells increase from 
their initially low numbers in the lamina propria and small intestine muscularis and 
submucosa during infection (Ogilvie and Jones, 1971; Arizono and Nakao, 1988), the 
peak in mast cell numbers seems to follow expulsion of Nb (Woodbury et al., 1984), 
with a small increase at day 5 and a large peak at day 15-17 (Keller et al., 1974; 
MacDonald et al., 1980). However, it has been noted that blood levels of mast cell­
specific rat mast cell protease II (RMCP II) peak at day 10, coinciding with a 
decrease in fecal egg counts and the expulsion of Nb (Woodbury et al., 1984). Rats 
are resistent to reinfection, and mast cell numbers rapidly peak at day 5-6 (Ogilvie 
and Jones, 197 1 ). Thus Nb infection and the associated mastocytosis is a reliable 
model system in which to study mast cell development and function. 
In addition to the increase in mast cells in the mesenteric lymph node, 
findings from the laboratory of William Paul have indicated that Nb infection may 
result in an increase in mouse mast cell and basophil precursors in the bone marrow 
and spleen. These progenitors, characterized by a lack of B and T cell markers, 
consist of 1-5% FcERI positive cells, and could produce IL-3 and IL-4, after 
activation with plate-bound IgG and IgE (Ben Sasson, et al., 1990). FACS analysis 
of this population demonstrated that the IL-4 producing capabilities could be 
segregated with the FcERI positive cells (Seder, et al., 199 1 a) .  Histochemical and 
elctron microscopic analysis showed these cells to have basophilic cytoplasm, 
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histamine-containing granules, and the majority appeared basophil or basophil­
myelocyte morphology (Seder, et al., 1991b). This population also contained 3-4% 
mast cell precursors, and methylcelluolose culture of these cells with IL-3 gave a 
mixture of mast cell and basophil colonies (Seder. et al., 199 1  b). Thus Nb infection 
and the associated mastocytosis appears to be a reliable system in which to study 
mast cell development and function. 
Several groups have demonstrated the ability of mast cells to be maintained 
on fibroblast monolayers, and these initial results indicated that mast cell 
proliferation on these monolayers was contingent upon direct contact with the 
fibroblasts (Jarboe et al., 1989). Jarboe, et al have described a cell termed the mast 
cell committed progenitor which can be obtained from the MLN of mice infected for 
14 days with Nb (Nb-MLN), but not naive mice (Jarboe et al., 1989). This 
committed progenitor was shown to proliferate and differentiate on either embryonic 
skin or 3T3 fibroblast monolayers, which do not produce IL-3 or IL-4, and could 
develop into mature CfMC (Jarboe et al., 1989). The cell was characterized as a 
nongranulated progenitor with a density of 1 .060 to 1 .070 g/cc (Jarboe et al., 1989), 
and is thought to be more mature than the bone marrow mast cell progenitor 
(Ashman et al., 1991) .  Commitment of this cell to the mast cell lineage was 
determined by its inability to yield other colony types in response to known growth 
factors, and the fact that culture of this cell with concentrated fibroblast-conditioned 
medium (FCM) or a source of IL-3 yielded almost 100% mast cells (Jarboe et al., 
1989). The activity of FCM in this system was in direct contrast to the results of 
other workers, and was the first report of mast cell progenitor development in culture 
in the absence of IL-3 or direct contact with fibroblasts (Jarboe et al., 1989). Also, 
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since normal bone marrow was able to generate mast cell colonies in response a 
source of IL-3 but not in response to fibroblast-eM, the committed progenitor was 
judged to be more mature than bone marrow mast cell progenitors (Jarboe et al., 
1989). 
Since naive MLN cells were not active m the methylcellulose mast cell 
progenitor assay using concentrated fibroblast-eM, the committed progenitor was 
thought to arise due to the unique microenvironment present in the Nb-MLN (Jarboe 
et al., 1989). Further work by Ashman, et al. characterized this microenvironment 
and recreated in vitro the stimuli sufficient to yield committed progenitors from 
normal bone marrow by determining the ability of Nb-MLN cells to produce 
cytokines involved in mast cell development during Nb infection. This was 
accomplished by stimulating Nb-MLN cells with Nb exosecretory antigen, and 
assaying culture supernatants (Ashman et al., 1991). It was shown that IL-3 and IgE 
peaked on day 1 1  of infection, three days before the peak in committed progenitor 
development (Ashman et al., 1991). IL-4 production by Nb-MLN cells peaked at day 
8 of infection (Ashman et al., 1991). These stimuli are known for their ability to 
enhance mast cell development and proliferation. IFN--y, which inhibits mast cell 
proliferation, peaked at day 14, and may play a role in suppressing progenitor 
development (Ashman et al., 1991). Most importantly, normal bone marrow was 
cultured in conditions mimicking the Nb-MLN, and it was shown that stimulation 
with IL-3 and IgE immune complexes yielded cells which could now respond 
fibroblast-eM alone (Ashman et al., 199 1). IgE immune complexes alone could even 
generate committed progenitor cells from normal bone marrow in the absence of IL-
3, possibly by inducing autocrine IL-3 production by these cells (Ashman et al., 1991). 
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According to this data, the mast cell lineage contains a committed progenitor which 
is more mature than the bone marrow mast cell progenitor but is still nongranulated. 
This cell can be generated from normal bone marrow through IgE receptors. 
No known growth factor was able to mimic the activity of fibroblast-eM 
(Jarboe et al., 1989). In an effort to characterize this factor and the committed 
progenitor, mast cell deficient mice were examined for their activity in the committed 
progenitor assay. In this manner it was found that fibroblast-eM from W /W, but 
not Sl/Sld mice was active in the assay. Conversely, Nb-MLN cells from Sl/Sld but 
not W /W mice were able to respond to fibroblast-eM, while both populations could 
respond to sources of IL-3 (Jarboe and Huff, 1989). It was therefore apparent that 
mice of the W /W strain lacked the ability to form committed progenitors, but could 
produce uncommitted progenitors as well as the fibroblast factor, while mice of the 
Sl/Sld genotype had the reverse mutation. Because the W locus has been 
demonstrated to encode the receptor tyrosine kinase c-kit (Chabot et a!., 1988; 
Geissler et a!., 1988), which is expressed on Nb-MLN cells or developing committed 
progenitors cultured in FCM express c-kit, but not naive MLN (Leftwich et a!., 1992), 
c-kit expression is likely to play an important role in committed progenitor 
development. This theory was given further credence when Leftwich, et a!. showed 
that anti-sense oligonucleotides to c-kit were shown to block committed progenitor 
development in response to fibroblast-eM, but not PWM-SCCM (Leftwich et al., 
1992). 
III) The W Allele and c-kit Receptor Tyrosine Kinase 
Mutations in the murine White Spotting (W) allele on chromosome 5 are 
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known to cause a phenotype that includes defects affecting coat color, 
hematopoiesis, and fertility (Geissler et al., 1988). This same set of developmental 
defects is seen in mice with mutations at the Steel (S/) locus (Bernstein et al., 1990), 
indicating a possible relationship between these two genes. These cell populations 
all require extensive migration during their development, and as such the W and Sl 
loci have been postulated to be function in cell-cell contact and migration. 
An intricate series of experiments by Kitamura demonstrated the relationship 
between W and Sl (reviewed in (Bernstein et al., 1991)). It was shown that while 
normal bone marrow could be transferred to W jU"' mice and cure their 
hematopoietic defect, W jU"' bone marrow could not rescue irradiated normal 
animals. Conversely, Sl/SF bone marrow could cure W jU"' mice or rescue normal 
irradiated mice, but adoptive transfer of normal bone marrow to Sl/SF mice did not 
correct their defect (Bernstein et al., 1991). From these experiments it was inferred 
hat the W mutation affected a progenitor cell, while S/ affected the tissue 
microenvironment. 
The receptor tyrosine kinase (RTK) c-kit was isolated due to its homology to 
the retroviral v-kit sequence, which induces feline sarcomas (Qiu et al., 1988). The 
characterization of this gene lead to its being linked with the W locus. Linkage to 
W was inferred from research showing kit expression in populations affected by W 
mutations, a decrease in c-kit message and protein in W mutants, and rearrangements 
of the c-kit gene in W mutants (Bernstein et al., 1990). Interspecific backcross 
analysis and somatic cell hybrid analysis showed that the c-kit proto-oncogene is 
encoded by the W locus (Chabot et al., 1988; Geissler et al., 1988), and as will be 
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described in detail below, the ligand for this proto-oncogene is the product of the Sl 
allele. 
Mouse c-kit is known to encode a 975 amino acid glycoprotein with a 21 
amino acid hydrophobic signal sequence, 518 amino acid extracellular domain that 
comprises 5 immunoglobulin-like repeats, a 24 amino acid transmembrane domain, 
and a large cytoplasmic tail that encodes 461 amino acids, making up a tyrosine 
kinase domain ((Qiu et al., 1988). The RNA encoding this structure is approximately 
5.5 kb in the mouse (Qiu et al., 1988). Although the predicted molecular weight of 
the protein is 109 kDa, there are nine potential sites for N-glycosylation (Majumder 
et al., 1988). Antibodies raised against the v-kit protein have been used to detect kit 
expression in various tissues, demonstrating the size of the kit protein to range from 
145-160 kDa (Majumder et al., 1988). c-kit has been mapped to the long arm of 
human chromosome 4 (4q31-34), a region that encodes genes similar to the murine 
W locus, including phosphoglucomutase-2, alpha-feto protein, and albumin (Qiu et 
al., 1988; Chabot et al., 1988). 
The v-kit protein is 95% homologous to its cellular counterpart at the amino 
acid level (Qiu et al., 1988). However, this acute transforming retrovirus encoded 
by the Harvey-Zuckerman 4-feline sarcoma virus (HZ4-FeSV) produces an 80 kDa 
gag-kit fusion protein that lacks extracellular and transmembrane domains, and has 
tyrosine kinase activity (Bernstein et al., 1990; Majumder et al., 1988). The structure 
of HZ4-FeSV is known to be: 5' gag-kit-pol-env 3' (Qiu et al., 1988). 
One of the most interesting findings about c-kit structure has been its 
homology to the M-CSF and PDGF receptors, both of which are RTKs (Majumder 
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et al., 1988; Qiu et al., 1988). All three RTK's have 5 Ig-like repeats (Bernstein et 
al., 1990), a transmembrane domain, and a cytoplasmic tyrosine kinase that is split 
into a tripartite structure, with the A TP binding and tyrosine kinase domains 
separated by a 70-100 amino acid interkinase domain which is thought to function 
in substrate recognition (Majumder et al., 1988; Qiu et al., 1988). The overall 
structures of the three proteins are similar on the extracellular domain as well; in 
each, four of the five Ig-like domains have paired cysteine residues (Majumder et al., 
1988). However, the amino acid homology is 20-26% between the three, and the 
interkinase domains have little homology, probably owing to their recognition of 
unique substrates (Qiu et al., 1988). 
RTK-mediated signalling is generally comprised of four events: receptor-ligand 
binding, receptor clustering, internalization of the receptor-ligand complex via 
clathrin-coated pits, and activation of the tyrosine kinase (Qiu et al., 1988; Majumder 
et al., 1988). The internalization of the receptor results in its degradation and 
subsequent down-regulation (Majumder et al., 1988). c-kit has been shown to 
undergo autophosphorylation in an in vitro kinase assay (Majumder et al., 1988), and 
the level of kinase activity is related to the severity of W mutations in the mouse 
(Majumder et al., 1988). Mutations which completely abolish kinase activity are 
lethal in their homozygous form (Majumder et al., 1988), however in heterozygous 
form, these mutations tend to be less severe than mutations which do not completely 
abrogate kit function (Bernstein et al., 1991). This initially perplexing finding was 
understood only after the revelation that kit receptors must dimerize to transduce a 
signal (Lev et al., 1991; Williams et al., 1992). Dimerization would be hindered by 
the presence of mutant, nonfunctional kit molecules; however a mutation which 
18 
abolishes kit, while lethal in homozygous form, would not produce defective 
molecules to interfere with dimerization in the heterozygous state. The finding that 
Kit functions as a dimer has lead some to postulate that what has been noted as 
autophosphorylation of receptors is actually trans-phosphorylation (Williams et al., 
1992). 
Both the PDGF and MCSF receptors, which share kit structure, have been 
shown to associate with phosphoinositol 3' kinase (PDK) via their kinase insert 
domains following ligand binding (Lev et al., 1992). PI3K is comprised of 85 kDa 
and 110 kDa fragments (Lev et al., 1992). The 85 kDa portion contains two src­
homology domains, which are thought to play a role in association of tyrosine kinases 
and their substrates (Lev et al., 1992). Studies have shown an association of the 85 
kDa PDK fragment with kit after SCF stimulation (Lev et al., 1991; Lev et al., 1992), 
which is coupled with kit autophosphorylation (Lev et al., 1992). Furthermore, site­
directed mutagenesis of the kinase insert domain decreases it association with PDK, 
as well as PI3K activity and receptor autophosphorylation (Lev et al., 1992). 
However, although PI3K is responsible for generating inositol phosphates, EKR 
stimulation did not result in detectable changes in inositol phosphate metabolism 
(Lev et al., 1991). Use of the EKR chimeric protein showed that phoshpolipase C 
(PLC) gamma, another mediator of inositol lipid metabolism, and the 
serine/threonine kinase Rafl are both tyrosine phosphorylated following receptor­
ligand interaction (Lev et al., 1991). Thus it appears that c-kit can associate with 
several second messenger molecules, but the effects on these molecules has not been 
determined. 
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Although murine W mutations affect the hematopoietic, germ cell and 
melanocytic lineages (Russell, 1979), studies of kit expression have linked it to an 
even more diverse group of tissues. Initial studies using a monoclonal antibody 
raised against the v-kit P80 protein demonstrated kit expression not only in the 
expected organs of spleen and testis, but a complex pattern of labelling was also seen 
in the brain (Majumder et al., 1988). Kit protein bas also been detected in human 
bone marrow, peripheral blood, and fetal liver (Papayannopoulou et al., 1991), as 
well as mast cells and bone marrow mononuclear cells (Lerner et al., 1991). Almost 
all in vitro derived clonogenic progenitors from bone marrow and CFU-S express Kit 
(Williams et al., 1992). Slot blot analysis of feline RNA demonstrates kit expression 
in bone marrow, thymus, spleen, liver, lymph node, kidney, lung, and brain (Qiu et 
al., 1988). Still other studies have shown kit expression in melanocytes and placenta 
(Bernstein et al., 1990) and the erythroleukemic cell lines HEL and LAMA (Ikeda 
et al., 1991). However, kit is not expressed in the lymphoid cell lines HL60, KG1, 
and U937, or non-erythroid myeloid cell lines (Ikeda et al., 1991; Bernstein et al., 
1990). In situ hybridization studies in the developing mouse embryo have shown a 
lack of kit expression prior to day 9 of gestation, followed by expression in brain, 
neural tube, and liver on day 11.5; melanocyte precursors demonstrate kit expression 
by day 13.5 (Keshet et al., 1991). Although W mutant mice are almost completely 
devoid of mast cells, levels of kit message do not appear to differ between W jW' and 
normal mice (Bernstein et al., 1991); however this may only indicate that 
transcription of the mutant allele is not affected, while the protein is nonfunctional. 
The expression of c-kit in primordial germ cells could explain the infertility 
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associated with many W mutations. Accordingly, recent findings have shown that 
expression of c-ldt on spermatogonia correlates with germ cell proliferation in the 
mouse (Manova et al., 1990; Sorrentino et al., 1991). Kit has also been demonstrated 
on murine oocytes, with a decrease in protein levels concomitant with ovulation 
(Horie et al., 1991; Manova et al., 1990). The present findings indicate a role for the 
early development and migration of both male and female germ cells. This is in 
agreement with the lack of migration of these progenitors seen in many W mutants. 
Since W mice have obvious coat color defects, it was logical to examine 
melanocytes for Kit expression; in fact human melanocytes have been shown to 
express Kit, and proliferate in response to SCF stimulation (Funasaka et al., 1992). 
Studies using EKR also showed this chimera to be tyrosine phosphorylated in 
melanocytes following ligand binding (Funasaka et al., 1992). Although Kit appeared 
to be upregulated in some melanoma cell lines examined, the Kit receptor was not 
autophosphorylated, as would be expected if it were constituitively activated 
(Funasaka et al., 1992). Also, SCF had no activity on primary nodular or metastatic 
melanomas that proliferate in the absence of exogenous factors (Funasaka et al., 
1992). From these results it appears that Kit functions in normal melanocyte 
development, but may not play a role in melanoma formation. 
While W mutants have not shown any obvious neurological deficits (Russell, 
1979), ldt and its ligand are visible at the earliest stages of neural differentiation, and 
there is a complex expression of both receptor and ligand in developing mouse brain, 
as detected by in situ hybridization (Keshet et al., 1991). Also, the outer boundary 
of the developing neural tube is surrounded by kit-expressing cells, which appear to 
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be migratory neural crest cells (Keshet et al., 1991). This has lead some to propose 
a role for the SCF-Kit complex in axon guidance during fetal development. 
Some data suggest that c-kit may play a role in some leukemias and solid 
tumors. An increase in tyrosine kinase levels, or the expression of retroviral tyrosine 
kinases have previously been linked to neoplastic phenomena: c-erbB2 is increased 
in mammary carcinomas and NIH 3T3 cells, while v-erbB induces avian 
erythroblastosis (Majumder et al., 1988). Since W mice are known to have decreased 
CFU-spleen, BFU-erythrocyte, and CPU-erythrocyte (Geissler et al., 1988), initial 
investigations have examined the expression of c-kit in hematopoietic cells. 
Monoclonal antibody YB5.B8 was raised against the blast cells of an acute 
myelogenous leukemia (AML), and this antibody has been demonstrated to recognize 
Kit on the surface of these cells (Lerner et al., 1991). Another anti-c-kit monoclonal 
antibody, SR-1, recognizes Kit expressed on the erythroleukemia cell line OCIM1 
(Broudy et al., 1992). Kit has also been detected on the blasts cells of acute 
nonlyrnphoblastic leukemia (Ikeda et al., 1991). The strongest link between Kit 
expression and neoplasia appears to be AML, since kit transcripts have been noted 
in 20 of 25 AML patients examined (Ikeda et al., 1991). Cells extracted from AML 
patients showed 7 of 12 populations had autophosphorylation of Kit in the absence 
of stimulation, and 6 of 11 populations could proliferate in the presence of rmSCF. 
However, Kit expression did not appear to correlate to French-American-British 
classifications or clinical symptoms (Ikeda et al., 1991). In a non-hematopoietic 
neoplasia, kit expression was detected in 81% of small cell lung cancer cell lines and 
12 of 13 tumors tested (Sekido et al., 1991). 
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A human equivalent to the W-encoded mutations in melanocyte development 
has apparently been found in the autosomal dominant disorder piebaldism. This 
disease results in the complete absence of melanocytes, and a subsequent lack of 
pigmentation, in patches of hair and skin, particularly on the forehead, chest, 
abdomen, and extremities (reviewed in (Spritz et al., 1992)). This trait has mutations 
associated with it at chromosome 4q12; human c-ldt is located on chromosome 4ql l-
12 (Spritz et al., 1992). Recently, missense and frameshift mutations in the kit 
tyrosine kinase domain resembling the W7 allele in the mouse were found in 3 
patients with piebaldism. The other defects in hematopoiesis and fertility associated 
with the W allele have not been noted in piebald individuals (Spritz et al., 1992). 
These findings add more credence to the proposed role for Kit in melanocyte 
migration and development. 
IV) Stem Cell Factor and the Sl Allele 
A dramatic series of papers in the October, 1990 issue of Cell reported the 
cloning of the S/ locus. These showed that the S/ gene encodes a glycoprotein growth 
factor which is now referred to as Stem Cell Factor (SCF) (Huang et al., 1990), Mast 
Cell Growth Factor (Williams et al., 1990), Steel Factor (Williams et al., 1992), or 
Kit Ligand (Huang et al., 1990). These publications also demonstrated that SCF was 
in fact the ligand for the c-ldt proto-oncogene product (Flanagan and Leder, 1990; 
Zsebo et al., 1990; Williams et al., 1990; Huang et al., 1990), proving a hypothesis put 
forth by several investigators. Murine SCF maps to the distal region of chromosome 
10, and is deleted in some S/ mutants (Copeland et al., 1990), while human SCF 
maps to chromosome 12q14.3-12qter (Geissler et al., 1991). The message encoding 
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mouse SCF is about 6kb (Zsebo et al., 1990). Although the active material isolated 
from BRL-3A cells migrated at 28-35 kDa, it could form noncovalent dimers of 70-90 
kDa ( 45), which correlates to the data above showing the necessity of dimer 
formation for Kit function. SCF is a glycoprotein composed of 248 amino acids 
arranged into extracellular, transmembrane and cytoplasmic domains (Williams et al., 
1992). The external domain is comprised of 164 amino acids, and is preceded by a 
25 amino acid signal peptide, which is cleaved during processing. The extracellular 
domain includes a 12-28 amino acid membrane spacer region and a membrane tether 
portion. A proteolytic cleavage site within the membrane spacer encodes a protease 
recognition site, which allows cleavage of the SCF molecule to yield a secreted form. 
The transmembrane domain is followed by a short cytoplasmic tail, which possesses 
no known enzymatic activities (Williams et al., 1992). The glycoprotein contains 4 
sites for N-glycosylation, 3 for 0-glycosylation, and is, in fact, heavily glycosylated, as 
rmSCF164 has a predicted molecular weight of 18 kDa but migrates at about 30 kDa 
(Lu et al., 1991). The Kit receptor binds SCF with an affinity of K0 = 3 x 10-8M 
(Flanagan and Leder, 1990). 
The overall domain architecture, dimerization, and proteolytic cleavage of 
SCF is similar to M-CSF (Bazan, 1991). The two growth factors have 16% amino 
acid identity, with 32% conserved amino acids, and a homologous three dimensional 
structure that includes the membrane spacer region and two disulfide bonds in the 
extracellular domain (Bazan, 1991). Other growth factors are known to be produced 
in membrane-bound or secreted forms, including TGFa, EGF, and TNFa (Flanagan 
et al., 1991). 
The observation that SCF can be produced as either a membrane-bound or 
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secreted growth factor was not completely unexpected. Jarboe, et al. bas reported 
the ability of Balb/c 3T3 fibroblast-conditioned medium to support the development 
of mast cell progenitors, in the same manner that others had shown fibroblast 
monolayers to induce mast cell differentiation (Jarboe et al., 1989). It is now known 
that alternative splicing of exon 6 determines the ability to produce either membrane 
or secreted SCF (Williams et al., 1992). This exon encodes a 28 amino acid segment 
of the protein that includes the protease recognition site; in its absence, only 
membrane SCF can be made. The expression of the protease recognition site results 
in about a 1:1 ratio of secreted and membrane SCF (Flanagan et al., 1991). The full 
length SCF transcript has been termed KL-1, and the truncated, membrane-only form 
KL-2 (Flanagan et al., 1991). Either form is effective in mediating cell-cell adhesion 
as a membrane protein (Flanagan et al., 1991). Truncation of SCF can be easily 
detected by the size of the protein, since secreted SCF bas a molecular weight of 25 
kDa, and membrane SCF a molecular weight of 38 kDa (Flanagan et al., 1991). The 
ratio of KL-1 to KL-2 bas been shown to vary greatly in tissues, from 5:1 to 0.6: 1 
(Flanagan et al., 1991). 
The different forms of SCF can explain the results of Jarboe, et al., since 
Balb/c 3T3 fibroblasts have been shown to produce large amounts of KL-1. Thus 
conditioned medium from these cells would contain much secreted SCF (Flanagan 
et al., 1991). However, it is apparent that membrane SCF may have a more 
important in vivo role than secreted SCF. Transfer of normal spleens to Sl/Sf mice 
resulted in a local curing of their hematopoietic deficit only; no systemic effects were 
seen. Also, creation of cell lines which could produce either membrane bound or 
secreted SCF transcripts only showed that membrane bound alone was capable of 
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supporting longterm hematopoiesis. Furthermore, in vitro expansion of primordial 
germ cells required the presence of membrane bound, and not secreted SCF. 
Finally, soluble rmSCF could only support in vivo hematopoiesis in large doses 
(Williams et al., 1992). Thus it appears that membrane-bound SCF may be more 
relevant to in vivo cell development. 
The most dramatic evidence of the important role membrane bound SCF 
plays in development and migration may be yielded from studies of the Sf/Sf mice, 
as reviewed by (Williams et al., 1992). These mice have a diluted coat color, 
macrocytic anemia, are sterile, and like other Steel mutants, they cannot be cured by 
bone marrow transplantation (Russell, 1979; Williams et al., 1992). However, initial 
studies showed these mice to contain message for SCF. Southern blot analysis 
showed Sf message to contain a 4kb deletion, resulting in a net loss of 175bp of 
translated sequence. Importantly, this deleted region encodes the transmembrane 
and cytoplasmic domains of SCF. Therefore, these mice can produce only the 
secreted form of the growth factor. Furthermore, this form has been shown to be 
active (Flanagan et al., 1991; Brannan et al., 1991). The fact that these mice can 
produce secreted SCF, yet still have the pleiotropic abnormalities associated with Sf 
mutations implies that membrane-bound SCF is critical for progenitor development. 
The designation of the Sf gene product as a "stem cell factor" has been drawn 
from its ability to induce the proliferation of many hematopoietic lineages, often 
acting at early stages in development. SCF has been shown to induce the 
proliferation of murine CFU-S alone, and can synergize with IL-l and IL-3 (de Vries 
et al., 1991). As stated earlier, almost all in vitro-derived hematopoietic progenitors 
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have been shown to express Kit, with the exception of IL-7-responsive cells (Ogawa 
et al., 1991). Also, while SCF has been shown to synergize with many known growth 
factors in the delta assay used by Moore and Warren, there is no evidence that SCF 
can support the self renewal of hematopoietic stem cells (reviewed in (Williams et 
al., 1992)). Therefore the actual ability of the Sf product to act as a "stem cell factor" 
may be somewhat overstated. However, the ability of SCF to act upon such a wide 
range of progenitor cells makes the possible clinical uses of SCF both diverse and 
important. 
Since both W and Sf mutants have deficiencies in erythropoiesis, the effect of 
SCF on erythrocyte development has been examined in depth. SCF has been shown 
to synergize with erythropoietin (Epo), enhancing colony number and size from BFU­
E and CFU-E, and may in fact be required for BFU-E differentiation to CFU-E 
(Williams et al., 1992). Also, SCF can correct the anemia of sr mice and induce 
baboon erythropoiesis (Andrews et al., 1991). In erythrocytic diseases, SCF has been 
shown to enhance erythroid colony formation from Diamond-Blackfan anemic bone 
marrow, and can increase fetal hemoglobin in BFU-E from sickle cell anemia 
patients (Williams et al., 1992). 
SCF also has an important role in mast cell development and function. Both 
culture-derived and peritoneal mouse mast cells have been shown to proliferate in 
response to SCF from 3T3 fibroblasts (Jozaki et al., 1991), and human mast cells can 
be derived by culturing human cord blood in SCF (Williams et al., 1992). SCF has 
been shown to induce mast cell chemotaxis (Meininger et al., 1992). Histamine 
release from rat or human mast cells can be stimulated by SCF as well, and some 
studies suggest the ability of SCF to induce mast cell-dependent acute inflammation 
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is 10 fold greater than substance P on a molar basis (Bischoff and Dahinden, 1992; 
Nakajima et al., 1992; Wershil et al., 1992). Injections of SCF have also proven to 
induce mast cell degranulation and associated respiratory distress in mice (Williams 
et al., 1992). From these studies it is apparent that SCF is important in mast cell 
development, maintenance, and function. 
Although Steel mice have no obvious T or B lymphocyte defects (Russell, 
1979), SCF has been shown to influence the development of lymphocyte precursors. 
SCF can promote the proliferation of both murine B220+ and B220- cells; however 
as these cells mature, they lose SCF-responsiveness, and SCF has no effect on mature 
B lymphocytes (Williams et al., 1992). In the T cell system, SCF transcripts have 
been detected in several thymic stromal cell lines, and SCF can enhance the 
proliferation of thymic lobe cells, especially in the presence of IL-7 (Williams et al., 
1992). Synergism of SCF with IL-2 or IL-7 to increase the growth of CD4_8_ cells in 
semisolid culture has also been noted, but as with B cells, SCF has no effect on 
mature peripheral T lymphocytes (Williams et al., 1992). 
Steel mutant mice are also not known to have mutations m 
megakaryocytopoiesis, however there is data to support a role for SCF in 
development of this lineage. SCF has been demonstrated to synergize with a number 
of cytokines to increase colony formation from BFU-MK and CFU-MK (Briddell et 
al., 1991). Although SCF can act at many stages of megakaryocyte maturation, no 
consist difference in platelet levels has been shown in Sl mice (Williams et al., 1992). 
Thus the role of SCF in megakaryocyte development is not fully understood. 
One of the most obvious mutations in Steel mice is their pigmentation 
abnormalities. Since melanocytes are migrating neural crest cells, studies have 
28 
examined the effect of SCF on the migration and proliferation of these cells and 
their precursors (Williams et al., 1992). Kehet, et al. published data showing a 
probable chemotactic role for SCF in the migration of melanoblasts during mouse 
development. These cells appeared to migrate along a SCF gradient, and 
melanoblasts were shown to express c-kit (Keshet et al., 1991). However, expression 
of SCF and its receptor appeared to decrease with melanocyte development (Keshet 
et al., 1991), and SCF can induce melanocyte proliferation only in the presence of 
phorbol esters; alone it supports their survival, and does not have any effect on 
melanin production (Williams et al., 1992). However, injections of anti-Kit 
antibodies into pregnant and non-pregnant mice showed that this antibody could 
modulate coat color in not only the developing fetus, but adult mice as well. This 
fits well with the data discussed above concerning the expression of c-kit and human 
piebaldism. The absence of SCF could prevent the proper migration of melanocyte 
progenitors, leaving the affected areas devoid of pigment. Thus it is obvious that 
SCF plays an important part in melanoblast migration and development, but its role 
in mature melanocyte function needs further study. 
The sterility of Steel mice also indicates an importance of SCF in germ cell 
development. In fact, in situ hybridization studies in the developing mouse have 
shown that primordial germ cells, which express Kit, may migrate along the genital 
ridge using a SCF gradient, much as the data presented for melanoblast migration 
has demonstrated (Keshet et al., 1991). SCF was shown to be expressed in the 
genital ridges in correlation with germ cell colonization, and expression ceases after 
colonization. In the adult animal, SCF is expressed in the granulosa cells 
surrounding the oocytes, and the oocytes are known to express Kit (Keshet et al., 
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1991). This pattern of SCF expression could explain the observed sterility of Steel 
mice. 
Lastly, as stated above for c-kit expression, Steel mice are not known to have 
any obvious neurological abnormalities (Russell, 1979). But as has been found for 
its receptor, SCF is expressed in and around the developing nervous system, and may 
function in neuron organization. In situ hybridization studies show SCF expression 
in neural floor plate early in gestation (Day 9.5), and later is expanded to include the 
ventrolateral regions, which are associated with motor neuron differentiation (Keshet 
et al., 1991). Recent experiments have indicated a role for the neural floor plate in 
organization of motor neuron tracts (Reviewed in (Keshet et al., 1991)). The in situ 
study also demonstrates kit expression in differentiating neural tubes and around its 
outer boundary, leading the authors to speculate that SCF may function as a 
chemoattractant for neurons or axons. By day 14.5, the forming motor neuron 
columns demonstrate SCF expression on neurons and cells in the ventral marginal 
zone that appear to be migrating toward the developing motor columns (Keshet et 
al., 1991). However, the expression of SCF in developing nervous tissue differs from 
that seen in the development of the germ cell pathway. While germ cell 
development appears to follow a SCF gradient, SCF is expressed in a localized 
manner in the nervous tissue, postulating the use of secreted SCF in neuronal 
migration and development (Keshet et al., 1991). SCF expression in the brain is 
equally complex to the aforementioned results concerning kit expression. Here again, 
SCF is postulated to play a trophic role in development. The embryonic thalamus 
shows high levels of SCF message (Keshet et al., 1991). This area functions to 
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mediate the organization of afferent inputs from the hypothalamus, olfactory, optic 
and spinal tracts, and the trigeminal sensory nuclei (Keshet et al., 1991 ), all of which 
requires extensive migratory regulation. SCF is also expressed in other areas of the 
developing brain, including the floor plate through the hindbrain and the length of 
the neural tube (Keshet et al., 1991). These findings implicate a potentially 
important role for this growth factor-receptor complex in the developing nervous 
system. 
V) Mast Cells and the Nervous System 
Mast cells are known to associate with peripheral nerves (Bienenstock et al., 
1991), usually located in the nerve sheath and endoneurium (Olsson, 1971). Some 
studies have shown close membrane association of mast cells and neurons (Bernstein 
and Lawrence, 1990). There is also literature to support mast cell/neuron "cross 
talk": electrical stimulation of nerves can induce mast cell degranulation, while mast 
cell degranulation has been shown to induce chloride ion flux in neurons 
(Bienenstock et al., 199 1). Furthermore, sensory neurons participate in inflammatory 
responses in many tissues, including the joints, skin, eyes, and respiratory tract 
(Bienenstock et al., 1991). There are many inflammatory diseases with no known 
role for lgE, including late onset and exercise-induced asthma, perennial rhinitis, 
angioneurotic edema, chronic idiopathic pruritis, and cholinergic urticaria (Church 
et al., 1989). Many of these are thought to involve nerve function, and all respond 
to standard H I  antihistamines (Church et al., 1989). Mast cells are known to 
respond to neuropeptides such as substance P and somatostatin, which can induce a 
weal and flare reaction upon injection into dermis (Church et al., 1989). Substance 
P bas also been shown to elicit histamine release from human Mere (Church et al., 
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1989), and substance P-induced inflammation can be blocked by antihistamines 
(Bienenstock et al., 1991). 
Mast cell numbers are increased in response to nerve damage and repair, as 
seen in amputation neuromas (Olsson, 1971) and peripheral nerve injury (Isaacson, 
1976); however, dramatic increases in mast cell numbers have also been noted to 
occur in pathological conditions involving Schwann cells (Isaacson, 1976). Schwann 
cells ensheathe and myelinate the peripheral nerves, and form the basal lamina upon 
which neurons reside (Ridley et al., 1989). The proliferation of these cells is tightly 
regulated, occurring only during development, after nerve damage, or in neoplastic 
phenomena such as neurofibromatosis (NF) (Davis and Stroobant, 1990 and 
Neuberger and DeVries, 1992). 
NF is one of the most common autosomal dominant disorders found in man, 
affecting 1 in 3500 people of all ethnic groups (Xu et al., 1990). This disorder has 
several characteristics associated with it, including multiple neurofibromas, cafe-au­
lait spots, axillary freckling, Lisch nodules, bony lesions, optic gliomas, and 
schwannomas (Gutmann et al., 1991). Half of all cases are spontaneous, and there 
is a wide range in severity of the disease (Goldberg and Collins, 1991). Two forms 
of NF are known to exist: NF1, or von Recklinghausen NF, and NF2, which usually 
manifests itself as bilateral acoustic NF (BANF). Neurofibromas, the hallmark of 
NF, are complex benign nerve sheath tumors composed of Schwann cells, perineurial 
cells, endothelial cells, fibroblasts, mast cells and other mononuclear leukocytes, and 
extracellular matrix material (Giorno et al., 1989; Riccardi, 1987). The NF­
associated cafe-au-lait spots are the result of hyperpigmentation caused by 
melanocytes (Riccardi, 1981). Malignant neurofibrosarcomas and schwannomas can 
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occur in NF, but are rare (Ponder, 1990). Thus while this disease is rarely fatal, it 
can be extremely disfiguring. 
The gene for NFl has been cloned and localized to pericentromeric 
chromosome 17 (Marchuk et al., 1991; Goldberg and Collins, 1991) It is a very large 
gene, encompassing 240 kilobases that encode a message of 13,000 bases, with a 
resulting 2818 amino acid product. Nfl is expressed in many tissues, and is conserved 
among species (Goldberg and Collins, 1991). The Nfl gene encodes a glycoprotein 
with a molecular weight of 250 kDa, and appears to be part of a 400-500 kDa 
complex (Gutmann et al., 1991; DeClue et al., 1991). NF1 has homology to the 
GTPase activating protein (GAP) and the yeast protein IRA1, both of which function 
to inhibit ras protooncogene signalling (Xu et al., 1990; Goldberg and Collins, 1991). 
Furthermore, NF1 can also interact with ras, indicating a possibly similar role to 
GAP and IRA1 (Goldberg and Collins, 1991). The NF1 gene is highly mutable (1 
in 10"'), offering an explanation for the high incidence of spontaneous NF cases 
(Ponder, 1990). But although nfl is apparently ubiquitously expressed, NF seems to 
affect cells of neural crest origin alone (Gutmann et al., 1991). 
The Schwann cell-containing lesions of NF contain large increases in mast 
cells. Mast cells are common in NF tumors and the associated schwannomas 
(Isaacson, 1976), and are present in greater numbers in these neoplasia than those 
seen most forms of nerve damage (Johnson, et al.,1989). There are apparent 
interactions between Schwann cells and mast cells that may regulate the proliferation 
and activation of both cell types. Nerve growth factor, a Schwann cell product, has 
been shown to induce mast cell proliferation (Matsuda et al., 1991), while mast cells 
are postulated to increase the in vitro growth of Schwann cells (George H. DeVries, 
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unpublished observations). Schwann cells are thought to be dependent upon 
glycosaminoglycans in the ground substance for their state of differentiation (Kessler 
et al., 1976; Poole and Zetter, 1983), and the action of mast cell proteases and 
glycosaminoglycan secretion may be able to affect this. Inflammatory reactions such 
as pruritis and facial flushing are common in NF, often accompanying rapidly growing 
neurofibromas (Giorno et al., 1989; Rothe et al., 1990). Standard H1 antihistamines 
such as diphenhydramine hydrochloride do not decrease this pruritis (Riccardi, 1987). 
However the mast cell stabilizing drugs ketotifen and disodium cromoglyate are 
effective (Riccardi, 1987; Riccardi, 198 1 ), and use of ketotifen also showed some 
decrease in neurofibroma growth (Riccardi, 1987). Thus mast cell-Schwann cell 
interactions may be important in the growth and maintenance of both populations. 
Schwann cells can be induced to proliferate by glial growth factor (GGF), 
transforming growth factor (TGF) B 1, TGFB2, and agents which increase cyclic AMP 
(cAMP) levels, such as dibutyryl cAMP or forskolin (Davis and Stroobant, 1990). In 
the presence of suboptimal doses adenylate cyclase - activating agents, platelet­
derived growth factor (PDGF), and acidic and basic fibroblast growth factors (FGF) 
can also function as Schwann cell mitogens (Davis and Stroobant, 1990). PDGF, 
FGFs, and TGFs-6 are involved in tissue repair after injury, and are released by 
platelets, endothelial cells, mesenchymal cells, macrophages, and in the case of 
TGFB, mast cells (Davis and Stroobant, 1990; Katz et al., 1991). Heparin, another 
mast cell product, is also known to potentiate the activities of FGFs (Rothe et al., 
1990). Therefore, Schwann cell proliferation appears to be linked to tissue repair, 
and may be influenced in part by mast cells. 
Schwann cells are not known to produce many growth factors, although they 
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do secrete NGF, especially in the presence of gangliosides (Ohi et al., 1990). 
Riccardi has reported the presence of autocrine and paracrine growth factors present 
in the supernatant of NF1 neurofibroma cultures, which could increase Schwann cell 
growth in vitro (Riccardi, 1986). Ridley, et al. have detected TGF6 mRNA in rat 
Schwann cells, and suggest that TGF6 may be produced as an autocrine growth 
factor by Schwann cell tumors (Ridley et al., 1989). Finally, a schwannoma-derived 
growth factor (SDGF) has been isolated that has homology to EGF and glial growth 
factor, and can stimulate proliferation of Schwann cells, fibroblasts, and astrocytes 
(Kimura et al., 1990). 
Materials and Methods 
Animals 
Female BALB/c mice were purchased from the National Cancer Institute (Frederick, 
MD). All mice were used at eight to ten weeks of age unless otherwise stated. 
Female Sprague Dawley rats were purchased from Harlan Sprague Dawley 
(Indianapolis, IN) at 200-250g weight, and were used within 3 months of delivery. 
Neonatal rat were also purchased from Harlan on day 1 after birth, and were used 
at two days of age. New Zealand White rabbits were purchased from Blue and Grey 
Rabbitry (Aylett, VA) at 2.5kg weight. 
Infection with Nippostron�lus brasiliensis (Nb) 
Nb were maintained as described (Huff and Justus, 1988). To obtain the mast cell­
committed progenitor (MCCP), mice were injected subcutaneously in the nape of the 
neck with 750 to 1000 l3 larvae, and were sacrificed at day 12-15 of infection. 
Cells and Cell Lines 
The contact-inhibited murine fibroblast cell line BALB/c 3T3 clone A31, the human 
fibrosarcoma cell line HT-1080, the murine mastocytoma P815, and the murine 
myelocytic cell line Wehi-3 were obtained from American Type Culture Collection 
(Rockville, MD). A rat Schwann cell line transfected with SV40 large T antigen 
(TRSC) has been described previously (Tennekoon et al., 1987) and was obtained 
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from George DeVries, Virginia Commonwealth University. The human malignant 
peripheral nerve sheath tumor line clone ST88-14 was generously given by Dr. 
Cynthia Morton, Brigham and Women's Hospital, Harvard University. Neonatal rat 
Schwann cells were prepared as described by Brockes, et al. (Brockes et al., 1979). 
Adult rat and human Schwann cells were prepared from sciatic or sural nerves, 
respectively, by a modification of Morrissey, et al. (Morrissey et al., 1991), using a 
digestion buffer of 0.05% collagenase, 1.25 u/rnl dispase, 1.0 mg/rnl hyaluronidase, 
0.02 mg/ml DNase, 15% fetal calf serum, and 25 mM HEPES in DMEM. The 
murine mastocytoma cell line MMC-34 was the gift of Dr. Reuben Siraganian, 
National Institute of Dental Research, NIH, and has been described previously 
(Barsumian et al., 1985). The murine mast cell line PT18 was the kind gift of Dr. 
Daniel Conrad, Department of Microbiology and Immunology, Virginia 
Commonwealth University, and was originally produced by Dr. Dov Pluznik, Division 
of Cytokine Biology, Food and Drug Administration. The human small cell lung 
cancer lines H146 and H510 were generously given by Dr. Geoff Krystal, Department 
of Hematology and Oncology, Medical College of Virginia. All cells were 
maintained in Dulbecco's medium which was supplemented with 2 mM L-glutamine, 
50 �-tg/rnl gentamicin, 100 U /rnl penicillin, 100 �-tg/rnl streptomycin, 1mM sodium 
pyruvate, 1mM oxaloacetic acid, 4nM 2-mercaptoethanol, and 10% FCS (cDMEM). 
The human SCF-responsive cell line M07E was the kind gift of Dr. James Griffin, 
Dana Farber Cancer Institute, Harvard University. These cells were maintained in 
cDMEM supplemented with 10 ng/rnl rhGM-CSF and 50 ng/rnl rhSCF. 
Preparation of Cell-Conditioned Medium (CM) 
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Cells were grown in a confluent state for 7 to 14 days in cDMEM, until medium was 
light orange in color. Conditioned supernatant was removed, centrifuged at 600 x g, 
and concentrated by ultrafiltration on a YM-10 filter (Amicon, Danvers, MA). 
Samples used in the M07E proliferation assay were first filtered through an XM-50 
ultrafiltration unit in 1.5M NaCl, and dialyzed against three changes of phosphate 
buffered saline. Pokeweed mitogen-stimulated spleen cell-conditioned medium 
(PWM-SCCM) was prepared as described previously (Jarboe and Huff, 1989). 
Recombinant Human Stem Cell Factor 
rmSCF164 was purchased from Genzyme Corporation (Boston, MA), and stored at -
70°C. 
Mast Cell-Committed Pro�:enitor Assay 
MCCP respond to 3T3 fibroblast-conditioned medium or IL-3 by formation of mature 
mast cell colonies in methylcellulose (Jarboe et al., 1989). A 2 ml mixture containing 
6 x l(f Nb-MLN cells/rnl, 0.8 rnl methylcellulose medium [11.5% (v/v) 2x MEM 
alpha medium (Gibco, Grand Island, NY), 70% (v/v) fetal calf serum, 2.5% 
deionized bovine serum albumin, 2.5% /-glutamine, 2.5% streptomycin solution, 50 
ug/rnl gentamicin, 5 x 10·5 2-ME], and 1.0 rnl 3% 4,000 centipoise methylcellulose 
(Fisher Scientific, Fair Lawn, NJ) was supplemented with 0.2 ml growth factor, unless 
otherwise indicated. This mixture was cultured in 24 well plates at 3rC in 5% C02 
for 13 days. Individual colonies were then enumerated with an inverted microscope 
at 100X magnification, and cytospin slides prepared for differential staining. The 
number of specific colony types in culture was determined by multiplying the number 
of total colonies counted by the percentage of cells present, as determined by cell 
staining. 
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Isolation of Ribonucleic Acid 
RNA was isolated from cultured cells by the RNAzol extraction procedure (Biotecx 
Laboratories Inc, Houston, TX), which uses a solution of guanidine isothiocyanate, 
phenol, and 2-mercaptoethanol to obtain a two phase separation of RNA from DNA 
and proteins. Concentration of RNA was determined by absorbance at 260nm, 
where 1 OD unit equals 40 1-'g/ml. 
eDNA Ubrazy Screenin� and Sequence Analysis 
A mouse NIH 3T3 fibroblast eDNA library packaged in Lambda Zap II vector 
(Stratagene, La Jolla, CA) was screened with a 5' end-labelled 30-mer 
oligonucleotide probe specific for mouse SCF, which was derived from the published 
sequence (Zsebo et al., 1990). Nitrocellulose filters lifted from the library were 
incubated overnight at 37°C with 106 cpm/ml of probe. Filters were then washed 4 
by 10 minutes at 37"C with 2X SSC, 0.2% SDS followed by one 30 minute wash at 
50°C with 0.5X SSC, o.2% SDS. From approximately 106 original plaques, 3 positive 
clones were obtained and In Vitro Excession using a R408 helper virus was 
performed as advised by Stratagene. The resulting pBluescript phagemid containing 
the eDNA was transfected into XL-1 Blue host E. coli. One clone was chosen for 
further study and was sequenced using US Biological Sequenase Version 2. 
Expression Vector 
A Bglii-BSU361 fragment encoding the secreted form of SCF was subcloned into 
PET-3d utilizing a 5' linker, which added an NCOI site and a start codon, and a 3' 
linker, adding the additional amino acids ASSLR, a stop codon, and a BAMHI site 
to the 3' end. These manipulations result in the expression of a message encoding a 
protein of 169 amino acids; therefore we have designated our recombinant Stem Cell 
Factor protein rmSCF169• 
Protein Purification 
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BL-21 E. coli containing the expression vector were grown at 28° C in LB (1% 
tryptone, 0.75% yeast extract, 0.34M NaCl) supplemented with 0.01 Mg, 22mM 
glucose, and 25JLg/ml ampicillin to an OD600 of 0.6-0.8, at which time IPTG was 
added to a final concentration of 1 mM. The cells were then cultured for 2 hours, 
pelleted and resuspended in 10mM tris, 0.5 mM EDT A, pH 7.8. Cells were then 
subjected to French Press (PSI = 20,000), and the supernatant was clarified and 
resuspended in 6M urea, 50 mM tris pH 7.8, 1% triton X-100, 5% glycerol, 0.1 mM 
phenylmethylsulfonylfluoride, and 0.1 mM dithiothreitol, incubated overnight at 4 oc 
with rocking, clarified by centrifugation, and partially purified using sizing 
chromatography. The resulting preparations of rmSCF169 were approximately 60-65% 
pure, as determined by densitometric analysis of polyacrylamide gels. To evaluate the 
activity of SCF169, preparations were tested in parallel with rmSCF purchased from 
Genzyme for their ability to stimulate proliferation of the mouse mast cell line MC9. 
Polymerase Chain Reaction and Nucleic Acid Transfer 
RNA (2JLg) samples were subjected to reverse transcription using 200U mouse 
mammary leukemia virus reverse transcriptase (Gibco BRL, Gaithersburg, MD) and 
oligonucleotide primers (see below) at 37°C for 60 minutes. eDNA was amplified 
using the Geneamp system of DNA amplification (Perkin Elmer Cetus, Norwalk, 
CT). Samples were incubated in a thermocycler (Perkin Elmer Cetus, Norwalk, CT) 
with oligonucleotide primers and Taq polymerase. Denaturing was carried out at 
95oc for 2 minutes, followed by primer annealing at sooc for 2 minutes, and primer 
extension at 72°C for 2 minutes. After 30 cycles were completed, samples were 
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incubated at 72 oc for 7 minutes, then stored at 4 oc. The amplified product was 
subjected to agarose gel electrophoresis and blotted to 0.2 JLm nytran {Schleicher and 
Schuell, Keene, NH). Nytran filters were crosslinked using an ultraviolet Stratalinker 
2400 {Stratagene, La Jolla, CA). Filters were probed overnight with a 32P-end 
labelled oligonucleotide at 37°C in a solution of 50% formamide, 0.1% SDS, .05M 
sodium phosphate pH 6.5, 5x SSC, 5x Denhardt's solution, and 0.25 mg/rnl yeast 
RNA, followed by washing with a solution of 0.2% SDS, 2X sse at 37°C for 4 X 10 
minutes, then 30 minutes at 60°C in a solution of 0.2% SDS, 0.5X SSC. Filters were 
exposed to Kodak X-OMAT AR film (Eastman Kodak Co, Rochester, NY) at -70°C 
for 1 to 5 days. 
Oli�onucleotide Primers and Probes 
5' and 3' oligonucleotide primers were designed with Primer Detective (CLONTECH 
Laboratories, Inc., Palo Alto, CA) from published sequences of the human and rat 
stem cell factor genes (Martin et al., 1990), the rodent IL-3 genes (Cohen et al., 
1986), the human c-kit sequence (Vandenbark et al., 1992), the rat c-kit sequence 
(Tsujimora, et al.,1991), the human actin sequence (Gunning et al., 1983), the mouse 
actin sequence (Leader et al., 1986), the human IL-3 sequence {Phillips et al., 1989), 
and the human GM-CSF sequence (Kaushansky et al., 1986). Oligonucleotide probes 
of 30 nucleotides in length were designed in the same manner. Oligonucleotide 
primers and probes were confirmed to lack significant homology to other rodent and 
human sequences in the Genbank and EMBL databases by the FastA algorithm of 
the GCG sequence analysis program. These primers and probes were synthesized 
in the Nucleic Acid Core Facility at Virginia Commonwealth University using an 
Applied Biosystems 380A DNA synthesizer. The sequences of each PCR primer and 
probe is in Appendix A 
M07E Proliferation Assay 
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1 x Ht M07E cells were placed into culture with cDMEM supplemented with the 
indicated concentration of growth factor or cell-conditioned medium. After 48 hours 
of incubation at 37°c and 5% C02 in a humidified incubator, 1.0 1-'Ci 3H-TdR was 
added to the cultures for 16 hours. Cells were then harvested onto absorbent glass 
paper and radioactivity associated with the cells was determined by liquid scintillation 
analysis (Packard 2200, Packard Instrument Co., Downers Grove, IL). 
Antibodies 
The following were purchased from Jackson ImmunoResearch Laboratories, Inc. 
(West Grove, PA): FITC-goat anti-rabbit IgG (H + L) F(ab')2; normal rabbit serum; 
rabbit lgG, whole antibody; PE-goat anti-mouse IgG (H + L) F(ab')2; normal mouse 
serum; mouse lgG, whole antibody. Mouse anti-human c-kit rnAb was purchased 
from Boehringer-Mannheim Biochemical, (Indianapolis, IN). Rat anti-mouse IL-3 
was purchased from Genzyme Imrnunobiologicals (Boston, MA). Mouse anti-human 
c-kit antibody YB5.B8 was the gift of Dr. Leonie Ashman, Department of 
Microbiology and Immunology, The University of Adelaide, Adelaide, South 
Australia. Rabbit anti-human SCF169 or anti-mouse SCF169 were produced in our 
laboratory by immunizing New Zealand White rabbits with 501-'g purified rhSCF169 
or rrnSCF169 in complete Freund's adjuvant, followed by boosting with 501-'g rhSCF169 
or rrnSCF169 in incomplete Freund's adjuvant. Animals were bled, serum harvested 
by centrifugation, and IgG fractions were collected using a protein A column (Pierce 
Chemical Co., Rockford, IL). Mouse anti-human nerve growth factor was originally 
obtained from ATCC, and was the kind gift of Dr. George DeVries, Virginia 
Commonwealth University, and was used as a neat solution. 
Hitochemical Stainin� of Cells 
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Toluidine blue stain was prepared by mixing 0.2% toluidine blue powder and 0.1M 
citric acid in 50% ethanol. The final pH of this solution was 1.0. Aldan blue stain 
was prepared at a final concentration of 0.5% in 0.3% glacial acetic acid. Safranin 
stain was made to a final concentration of 0.1% in 0.1% acetic acid. Cytospin slides 
were stained at room temperature with acidic toluidine blue for 45 minutes to detect 
the presence of metachromatic cells (mast cells). Alternatively, slides were stained 
with aldan blue for 10 minutes, followed by safranin for 10 minutes. A cell was 
denoted as "positive" for safranin staining if > 20% of the granules in the cell were 
stained with safranin. 
Immunofluorescent Stainin� of Cells 
Cells were harvested by centrifugation and washed once in PBS supplemented with 
10% NGS (PBS/NGS). 1 X 106 cells were incubated in a volume of 100 �-tl with 
primary or control antibody at the concentration denoted for 45 minutes at 4 oc. 
Cells were then washed twice with PBS/NGS, and resuspended in a 100�-tl volume, 
to which 5 �-tl secondary antibody was added. Cells were incubated at 4 oc for 30 
minutes, washed twice with PBS/NGS, and analyzed by flow cytometry. 
Flow Qrtometzy 
Fluorescently labelled cells were analyzed on an Epics 753 Flow cytometer (Coulter 
Corp., Hialeah, FL) or a Becton Dickinson Facscan Flow Cytometer (Becton 
Dickinson Immunocytometry Systems, Braintree, MA). FITC and PE emissions were 
observed using standard filters. Propidium iodide staining was used to exclude non­
viable cells, after which 10,000 cells were analyzed. 
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Stimulation with PMA 
Nonadherent cells were incubated in cDMEM containing 50 ng/ml PMA for 60 
minutes at 37°C with rocking. After incubation, cells were washed with cDMEM to 
remove PMA, and used as described. 
Isolation of Peritoneal Cells 
Murine or rat peritoneal cells were harvested through peritoneal lavage by injecting 
PBS (5 ml/mouse; 35 ml/rat) into the peritoneal cavity of freshly sacrificed animals. 
PBS was extracted with a pasteur pipette, and cells were obtained by centrifugation. 
Percoll Density Separation 
Percoll was purchased from Pharmacia Fine Chemicals (Piscataway, NJ) at a density 
of 1 .3 1  g/ml. This stock solution was diluted with lOX PBS and dH20 to yield the 
desired final density. Cells were layered on percoll gradients and centrifuged at 1200 
x g in an IEC tabletop centrifuge model HN-SII (IEC, Needham Heights, MA) for 
25 minutes at room temperature. Cells were removed from gradient interfaces with 
a pasteur pipette and washed with cDMEM by centrifugation. Peritoneal mast cells 
( > 98%) were obtained by centrifuging 2x 107 peritoneal cells on a gradient of percoll 
at density 1 .082 g/ml as described above, and harvesting the pellet 
Placental Tissue RNA 
In collaboration with Dr. Scott Kauma, Department of Obstetrics and Gynecology, 
Medical College of Virginia, placental tissues were obtained from donors after 
informed consent, tissues were homogenized with a Tekmar Tissuemizer (Tekmar 
Co., Cincinatti, OH), and RNA was extracted as described. 
Northern Analysis 
RNA was separated by electrophoresis on a 1% formaldehyde agarose gel at 25v for 
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16  hours, then capillary blotted to 0.2JLm nytran filters (Schleicher and Schuell, 
Keene, NH) and probed with a 32P-labelled 539 nt human SCF eDNA probe, which 
was random prime labelled using an oligolabelling kit (Pharmacia LKB 
Biotechnology, Uppsala, Sweden) at the manufacturer's specifications. eDNA probe 
was placed at a final concentration of lxl<f cpm/ml. Filters were pre-washed at 
4ZOC in a solution of 20 mM tris, pH 8.0, 1 M  NaCl, lmM EDT A, and 0. 1 %  SDS for 
1 hour with rocking. Filters were then pre-hybridized with a solution of 50% 
formamide, 5x SSC, 5x Denharts, 0. 1 %  SDS, lOmM sodium phosphate, pH 6.5, and 
100 l'g/ml salmon sperm DNA for 1 hour at 42°C with rocking, then probed for 16  
hours under the same conditions. Filters were washed in a solution of 20 mM 
sodium phosphate, and 0. 1 %  SDS with 4x SSC, followed by 2x SSC, then O. lx SSC. 
Each wash was carried out at 56°C. Filters were exposed to Kodak X-OMAT AR 
film (Eastman Kodak Co, Rochester, NY) at -70°C for 1 to 5 days. 
Isolation of Polyadenylated RNA 
Columns were prepared with oligo-dT sepharose beads (Pharmacia LKB 
Biotechnology, Uppsala, Sweden) and washed with 5 column volumes of binding 
buffer (O.OlM tris, pH 7.5, 0.5M NaCl, 1mM EDTA). RNA ( 1-2 mg) was 
resuspended at 5 mg/rnl in elution buffer (.01M tris, pH 7.5, 1mM EDTA) and 
heated to 65°C for 5 minutes, then kept on ice. RNA was diluted 1 : 1  with 2x 
binding buffer and applied to the column. Effluent was collected and re-applied 
twice, after which time the column was rinsed with 5 volumes binding buffer, 
followed by 5 volumes wash buffer (0.01 M tris, pH 7.5, O. lM NaCl, 1 mM EDTA). 
Eluate was then collected by washing the column with 2 volumes elution buffer. 
RNA in this fraction was precipitated by the addition of 0. 1 volume 3M sodium 
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acetate and 2.5 volumes 100% ethanol for 16 hours at -80°C. Precipitate was 
collected by centrifugation at 15,000 rpm in a microcentrifuge (Costar, Cambridge, 
MA), and resuspended in DEPC-dH20. Concentration of RNA was determined by 
absorbance at 260 nm. 
Results 
I) Known Growth Factors Cannot Mintic 3T3-CM Activity 
This laboratory has previously described a mast cell colony stimulating activity 
present in the supernatant of 3T3 fibroblast cultures. Initial experiments 
demonstrated that the factor was a protein with Mr 5-50 kDa (Jarboe et al., 1989). 
This factor was able to give rise to mast cell colonies from Nb-MLN cells after a two 
week culture period in methylcellulose. To deterntine the identity of the colony 
stimulating factor in 3T3-CM, various known growth factors were added to 
methylcellulose cultures to ntintic the activity found in the fibroblast-conditioned 
medium. In addition to the list of known growth factors previously shown to be 
unable to support the development of mast cell colonies from Nb-MLN cells, bFGF 
(5 ng/rnl,25 ng/rnl,50 ng/rnl), TBFJ3 ( 1  ng/rnl,5 ng/ml, 10 ng/rnl), and IL-9 (5, 10, 100 
u/ml) also had no activity. These and other previously tested growth factors are 
shown in Table VII (See Appendix B). 
Of the factors tested, only IL-3 was found to generate mast cell colonies from 
Nb-MLN cells. However, 3T3 fibroblasts have been shown not to produce IL-3 
(Jarboe et al., 1989), and RNA extracted from BALB/c 3T3 fibroblasts was 
demonstrated by RT-PCR to lack message for IL-3 (Figure 32, Appendix B). 
Therefore we could not attribute the activity in 3T3-CM to this growth factor. This 
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lead us to the conclusion that an uncharacterized mast cell growth factor was 
produced and secreted by 3T3 fibroblasts. 
II) Cloning of Mouse SCF169 
After having concluded that the fibroblast-produced growth factor was likely 
to be a new one, our laboratory contacted AMGEN Biologicals to initiate a 
collaborative cloning effort. This project began immediately as a six month unfunded 
collaboration, during which time our Nb-MLN culture system was shown to be able 
to read blinded samples (Table I�. Appendix B). However, this collaboration was 
ended when AMGEN set new stipulations not part of the original agreement. . As a 
result of the delay, we were unable to clone the growth factor prior to the 1990 Cell 
publications by three groups describing the cloning and isolation of a mast cell 
growth factor encoded by the S/ locus (Copeland et al., 1990; Flanagan and Leder, 
1990; Anderson et al., 1990; Williams et al., 1990; Huang et al., 1990; Zsebo et al., 
1990). However, we did use the published information to derive clones of mouse and 
human SCF in order to more quickly accomplish our goals of elucidating the signals 
for mast cell growth and differentiation. 
In a joint effort lead by Dr. Julie Leftwich of this laboratory, a clone of mouse 
SCF was obtained by screening a eDNA library from NIH 3T3 fibroblasts. Using a 
labelled oligonucleotide probe, a clone of 826 nucleotides that encodes the full length 
mSCF protein and included 289 nucleotides of untranslated 5' sequence was isolated 
as described in Materials and Methods. A prediction of the three dimensional 
structure of this protein, as determined by the Chou-Fasman algorithm is shown in 
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Figure 1 .  A portion of the clone encoding 169 amino acids at the amino terminus 
of the SCF protein was inserted into the expression vector PET-3d (Figure 1 ), as 
described in detail in Materials and Methods. This fragment includes the 
extracellular region and extends to, but does not include the so-called "membrane 
tether" region of the protein, which is known to include a proteolytic cleavage site 
(Williams et al., 1992). As shown in Figure 2, the amino acid sequence of our SCF169 
clone is nearly identical to that obtained by AMGEN, with the exception of five 
amino acids found at the carboxyl terminus of our clone. Thus, our clone will be 
referred to as SCF169, and AMGEN's as SCF164• 
III) Recombinant Stem Cell factor Promotes Maximal Mast Cell Colony 
Formation from Committed Progenitors 
Because no known factor could mimic the effect of 3T3-CM in the committed 
progenitor assay, and 3T3 fibroblasts were shown to produce SCF (Zsebo et al., 
1990), we determined if rmSCF169 or rmSCF164 could replace FCM in methylcellulose 
cultures. 
Nb-MLN cells (6x 10S /ml) were cultured in the presence of rmSCF169 or 
rrnSCF164 at 5, 50, 100, or 200 ng/ml for 13 days, and the number of mast cell 
colonies was determined as described in Materials and Methods. As shown in Figure 
3, both forms of SCF were able to generate mast cell colonies in these cultures. 
rrnSCF164 has greater activity in this assay due to its greater purity. While rmSCF169 
is 99% pure, rmSCF169 is approximately 65% pure, as determined by densitometric 
analysis of polyacrylamide gels, and has hence been denoted as "crude" rmSCF169 in 
Figure 3. This dose response curve was used to calculate the half-maximal 
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Figure 1 
Chou-Fasman algorithm prediction of rmSCF three dimensional structure. rmSCF169 
is contained between the two vertical bars. Diamonds represent area of 
hydrophilicity; ellipses indicate areas of hydrophobicity. Arrowhead shows 
"membrane tether" region. 
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Figure 2 
Amino acid sequences of rmSCF164 (Top) and rmSCF169 (Bottom). 
. . 
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1 MEICGNPVTDNVKDITKLVANLPNDYMITLNYVAGMDVLPSHCWLRDMVI 5 0  
· I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
2 KEICGNPVTDNVKDITKLVANLPNDYMITLNYVAGMDVLPSHCWLRDMVI 5 1  
. . . . 
5 1  QLSLSLTTLLDKFSNI SEGLSNYS I I DKLGKIVDDLVLCMEENAPKNIKE 1 0 0  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  
5 2  QLSLSLTTLLDKFSNI SEGLSNYS I I DKLGKIVDDLVLCMEENAPKNIKE 1 0 1  
. . 
1 0 1  SPKRPETRSFTPEEFFSI FNRSIDAFKDFMVASDTSDCVLSSTLGPEKDS 1 5 0  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  
1 0 2  SPKRPETRSFTPEEFFSI FNRSIDAFKDFMVASDTSDCVLSSTLGPEKDS 1 5 1  
1 5 1  RVSVTKPFMLPPVAASSLR 1 6 9  
1 1 1 1 1 1 1 1 1 1 1 1 1 1  
1 5 2  RVSVTKPFMLPPVA 
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Figure 3 
Stimulation of committed progenitor development by recombinant SCF. Nb-MLN 
cells were cultured in the presence of the indicated concentrations of rmSCF169, 
rmSCF164, 15X 3T3-CM, PWM-SCCM, or medium alone for 13 days, after which time 
colonies were counted and cytospin preparations made. Percent mast cells was 
determined by acidic toluidine blue staining of cytospin preparations. Shown are the 
means and standard error measurements of duplicate wells in a 24 well plate from 
one of 5 representative experiments. 
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concentration of rmSCF164 as 12 ng/rnl. SCF stimulation of Nb-MLN cells proved 
to be greater than 3T3-CM both in terms of the number and size of colonies 
generated in most experiments (Figure 3 and Figure 4 ). While 3T3 FCM gave rise 
to 1 10 mast cell colonies, rmSCF169 and rmSCF164 at 200 ng/ml yielded 136 and 178, 
respectively. Moreover, the number of cells in colonies derived from 3T3 FCM 
stimulation was about 100, whereas either source of SCF lead to the formation of 
colonies containing 500 cells or greater at dosages of 100-200 ng/rnl. This difference 
in colony size could be due to a greater amount of SCF present in rmSCF than is 
found in 3T3 FCM, or the stimulation of distinct mast cell progenitor subsets by 3T3 
FCM and SCF. Three subsets of mast cell progenitors have been described in the 
peritoneal cavity, based upon the colony size and cell phenotype they generate 
(Kanakura et al., 1988). By colony size criteria, 3T3 FCM could be postulated to act 
upon Medium (M)-CFU-Mast, which yield colonies containing 32-500 cells, while 
rmSCF could stimulate Large (L)-CFU-Mast, which form colonies with greater than 
500 cells each (Kanakura et al., 1988). 
Mast cells have two distinct phenotypes: connective tissue and mucosal {See 
Literature Review). Although all mature mast cells will stain metachromatically with 
toluidine blue, connective tissue phenotype mast cells stain preferentially with 
berberine sulfate or safranin, both of which bind to the heparin proteoglycan 
possessed by these, but not mucosal mast cells (reviewed in and Schwartz and 
Huff, 1992). While M-CFU-Mast colonies stain with safranin or berberine sulfate, 
L-CFU-Mast do not (Kanakura et al., 1988). The state of differentiation of the cells 
derived from culture with SCF was determined by staining cytospins prepared from 
methylcellulose cultures with toluidine blue, berberine sulfate or aldan bluejsafranin. 
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The phenotype of these cells is shown in Figure 5. Toluidine blue staining resulted 
in the appearance of metachromatic granules in 99% of cells stimulated with 100 
ng/ml of rmSCF169 or rmSCF164, respectively, and 90% of cells cultured with 31'3 
FCM {Average of five separate experiments). Thus these cells appear to be mature 
mast cells. 
Stimulation with 100 ng/ml rmSCF164 yielded cultures where 54% of the cells 
stained with berberine sulfate, while 67% of cells grown with 31'3 FCM were 
berberine sulfate positive. Safranin staining gave similar results, with 82% of cells 
cultured with SCF staining positive, versus 89% of 31'3 FCM-stimulated cells 
(Average of five separate experiments). These results indicate that culture of Nb­
MLN cells with recombinant SCF resulted in the formation of colonies with heparin­
containing mast cells, indicative of the connective tissue phenotype. Thus rmSCF 
alone can substitute for 31'3 FCM both in the proliferation and differentiation of 
mast cell-committed progenitors. 
Previous results from this laboratory have shown that 31'3 FCM is not active 
on naive MLN cells (Jarboe et al., 1989). After demonstrating the activity of rmSCF 
on Nb-MLN cells, we cultured naive MLN cells under similar conditions, but were 
not able to obtain mast cell colonies (Data not shown). Similarly rhSCF, which has 
been shown to be 800 fold less active on rodent progenitors than on human 
progenitors (Zsebo et al., 1 990), also lacked activity in this assay (Data not shown). 
IV) Schwann Cell Neoplasia and Mastocytosis: The SCF Connection 
Schwann cells myelinate the peripheral nervous system, and are the major cell 
type found in neurofibromas and schwannomas. Mast cells have been shown to 
associate with Schwann cells (Isaacson, 1976), and a prominent mast cell hyperplasia 
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Figure 4 
Photomicrograph of developing ( Day 13) colonies i n  methylcel lulose after stimu lation 
of Nb -MLN ce lls  with (A) 15X 3T3 FCM, or (B) 50 ng/ml rmSCF169• Magnification 
200x. 
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Figure 5 
Phenotype of cells derived from methylcellulose culture of Nb-MLN cells with 
rmSCF. (A) Photomicrographs of cytospin preparations derived from methylcellulose 
culture of Nb-MLN cells for 13 days with 50 ng/ml rmSCF169• Cells were stained 
with: ( 1 )  acidic toluidine blue, (2) aldan bluejsafranin or (3) berberine sulfate as 
described in Materials and Methods. (B) Percentage of cells which stained with 
acidic toluidine blue, safranin, or berberine sulfate after culture of Nb-MLN cells 
with 100 ng/ml rmSCF164, 15X 3T3 FCM, or PWM-SCCM. Values represent the 
mean of five separate experiments. 
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(B) Phenotype of  Cells Derived from Culture with Stem Cell Factor 
Stimulus Toluidine Blue Berberine Sulfate Safranin 
(Histamine) (Heparin) (Heparin) 
100 ng/ml SCF 99% 54% 8 1 %  
1 5 X  3T3 FCM 90% 67% 89% 
PWM-SCCM 99% 1 %  0% 
62 
has long been noted concomitant to either of these noted Schwann cell neoplasia 
(Giomo et al., 1989). Because the findings of this laboratory have demonstrated the 
ability of SCF to induce mast cell development from committed progenitors, and the 
results of others that have indicated a role for SCF in mast cell proliferation, 
activation, and migration (Jozaki et al., 1 99 1 ;  Williams et al. ,  1 992; Meininger et al., 
1 992; Bischoff and Dahinden, 1992; Nakajima et al., 1992; Wershil et al., 1 992), we 
sought to determine if SCF could be produced by Schwann cells, offering an 
explanation for the mast cell hyperplasia associated with Schwann cell proliferation. 
To determine if Schwann cells express SCF message, RNA extracted from the 
human malignant schwannoma cell line ST88- 14, derived from a dermal peripheral 
nerve schwannoma, and an SV40-transfected neonatal rat Schwann cel l  l ine (TRSC) 
was subjected to RT-PCR using primers specific for rat and human SCF. As shown 
in Figure 6, both Schwann cell lines exhibited expression of an 830 nucleotide band 
after RT-PCR. This is the expected size of the SCF transcript, and a band of 
identical size was amplified from HT1080 RNA (Figure 6), a cell line known to 
express SCF (Martin et al., 1990). Thus, both ST88- 14 and TRSC Schwann cell lines 
express SCF message. 
SCF protein should be detectable in the culture supernatant of cells which 
express the KL- 1 form of SCF, since this transcript leads to the cleavage of 
membrane-bound SCF and its subsequent release as a secretable product. However, 
cells expressing the KL-2 transcript produce only membrane-bound SCF and would 
have no activity in their culture supernatant (See Literature Review). To determine 
if either of the Schwann cells l ines which have shown expression of SCF message 
could produce secretable SCF, conditioned medium (CM) from the transfected rat 
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Schwann cells and ST88- 14 Schwann cell lines was concentrated 50 fold and 
employed in the SCF-dependent committed progenitor methylcellulose assay or an 
SCF-dependent proliferation assay. 
Transfected rat Schwann cell-CM was able to induce the formation of mast 
cell colonies from Nb-MLN cells in a dose responsive manner (Figure 7), although 
this conditioned medium was less active than 3T3-CM, generating 79 mast cell 
colonies at its highest concentration, as compared to 108 colonies per well induced 
by 3T3-CM. Since only IL-3 and SCF have demonstrated activity in this assay, RT­
PCR was used to determine if transfected rat Schwann cells express IL-3 message. 
As shown in Figure 8, RNA extracted from these cells could not be amplified with 
primers specific for IL-3 to yield the expected 550 base pair band expressed by the 
WEHI-3 positive control cell line. This same preparation of transfected rat Schwann 
cell RNA could, however be amplified by RT-PCR to detect SCF or actin expression 
(Figure 6, and data not shown). Thus the RNA extracted from this Schwann cell line 
appears to be intact. Because conditioned medium from transfected rat Schwann 
cells is able to induce mast cell colony formation from committed progenitors, and 
IL-3 message is not detectable in RNA extracted from this cell line, the activity of 
transfected rat Schwann cell-CM indicates the production of SCF by this Schwann 
cell line. 
Since hSCF has been shown to lack activity in the committed progenitor assay, 
we anticipated that ST88- 14-CM would also be inactive in this assay, and in fact this 
was the case (Data not shown). Therefore, we employed a proliferation assay to 
detect secreted hSCF from the ST88- 14 cell line. The human megakaryocytic cell 
line M07E has been shown to be dependent upon GM-CSF, IL-3 or hSCF for its 
64 
Figure 6 
RT-PCR for SCF expression by Schwann cells. Total RNA was extracted from cell 
lines and subjected to RT-PCR using primers specific for human or rat SCF. PCR 
was carried out as described in Materials and Methods, with a sooc annealing 
temperature for 30 cycles. Arrow head indicates location of expected 830 base pair 
product. Samples are (A) transfected rat Schwann cells, (B) ST88- 14, (C) HT1080, 
(D) Control sample (-eDNA). 
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Figure 7 
Stimulation of committed progenitors with transfected rat Schwarm cell-CM. Nb­
MLN cells were cultured in methylcellulose for 13  days in the presence of SOX 
transfected rat Schwarm cell-CM, 15X 3T3-CM, PWM-SCCM, or Medium alone. 
Percent mast cells was determined by staining cytospin slides with acidic toluidine 
blue as described in Materials and Methods. Values represent the means and 
standard error measurements of duplicate wells of a 24 well plate from a 
representative experiment. Duplicate experiments yielded similar results. 
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Figure 8 
RT-PCR for IL-3 from transfected rat Schwann cells. RT-PCR using primers specific 
for rodent IL-3 was carried out on samples containing 2�-tg total RNA from (A) 
transfected rat Schwann cells or (B) WEHI-3 cells, or (C) a sample lacking RNA, as 
described in Materials and Methods, using an annealing temperature of 50°C for 30 
cycles. Arrowhead indicates expected 547 base pair reaction product. 
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proliferation (Kuriu et al., 1 99 1). To first determine if ST88- 14 cells express GM­
CSF or IL-3, RNA extracted from this cell  line was subjected to RT-PCR 
amplification using primers specific for these growth factors. As shown in Figures 
9 and 10, ST88- 14 RNA could not be amplified to detect the expected IL-3 or GM­
CSF bands, althoughthis same preparation of RNA was used to detect SCF (Figure 
6) and actin (Data not shown) messages. M07E cells were then cultured in the 
presence of varying concentrations of ST88- 14-CM. However, this medium was 
unable to support M07E proliferation (Figure 1 1 ), implying that no detectable SCF 
was secreted by ST88- 14 cells. 
Our laboratory bas produced antibodies to rhSCF169 by immunizing rabbits 
with recombinant proteins as described in Materials and Methods. This antibody will 
bind to protein extracted from bacteria induced to express the recombinant SCF 
protein, but not to protein extracted from uninduced bacteria (Data not shown), and 
recognizes both glycosylated and unglycosylated forms of rhSCF in western blot 
analysis (Scott Kauma, Obstetrics and Gynecology, Medical College of Virginia, 
unpublished observations). Using this antibody, Schwann cells were analyzed for the 
ability to express membrane-bound SCF as determined by flow cytometric analysis. 
HT1080 cells, which express SCF (Martin et al., 1990), exhibited specific binding 
when stained with anti-hSCF169 as determined by fluorescent microscopy, indicating 
the presence of surface-bound SCF. However, the human small cell lung cancer line 
H5 10, which does not express SCF message (Personal communication, Dr. Geoff 
Krystal, Hematology and Oncology, Medical College of Virginia), did not stain above 
background with this antibody (Data not shown). Labelling of transfected rat 
Schwann cells with the anti-hSCF169 antibody resulted in an increase in fluorescence 
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Figure 9 
RT-PCR for IL-3 from ST88- 14 schwannoma cells. Total RNA was extracted from 
(A) ST88- 14, (B) PMA/ionomycin-stimulated Jurkat T cells (positive control) or (C) 
5637 bladder cell carcinoma cells (negative control) and subjected to RT-PCR using 
primers specific for human IL-3. Lane (D) is a negative control containing all 
reactants except RNA. Reaction was carried out as described using an annealing 
temperature of sooc for 30 cycles. Arrowhead indicates expected 370 base pair 
reaction product. 
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Figure 10  
RT-PCR for human GM-CSF expression in ST88- 14  schwannoma cells. RT-PCR 
using primers specific for human GM-CSF was carried out on samples containing 2p.g 
total RNA extracted from (A) ST88- 14 or (B) 5637 cells, or (C) a sample Jacking 
RNA as described in Materials and Methods, using an annealing temperature of 
50°C for 30 cycles. Arrowhead indicates the expected 393 base pair product. 
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Figure 1 1  
Cell proliferation assay to detect SCF. SCF-dependent M07E cells were cultured 
in the presence of the indicated concentrations of rhSCF169, SOX ST88- 14-CM, or SOX 
cDMEM for 48 hours, after which time 1 J.LCi 3H-TdR was added to each well. Wells 
were pulsed for 16 hours and cells harvested to absorbent glass paper with a 
multiport cell harvester. Radioactivity associated with cells was determined by liquid 
scintillation analysis. Values represent the means and standard errors of six wells 
from two separate experiments. Duplicate experiments gave similar results. 
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beyond rabbit IgG control antibody (Figure 12), as did staining of the ST88- 14 
Schwannoma cells (Figure 13). These results indicate that both Schwann cell lines 
express membrane-bound SCF. The detection of SCF protein in transfected rat 
Schwann celi-CM and the subsequent staining of transfected rat Schwann cells for 
surface SCF correlates with production of the KL-1 transcript, while surface SCF 
expression by ST88-14 cells and the lack of detectable SCF in culture supernatants 
is indicative of KL-2 expression by this cell line. 
To determine if SCF is expressed by normal Schwann cells, primary neonatal 
rat Schwann cells (NRSC) were isolated from the sciatic nerve of two day old rats 
as described in Materials and Methods, cultured for several days, and stained with 
anti-hSCF169 antibody. At the time of staining, these cultures contained less than 1 %  
contaminating fibroblasts, as determined by morphological criteria. As shown in 
Figure 14, the majority of this population exhibited a shift in fluorescence beyond 
control IgG after anti-hSCF169 staining, indicating SCF expression by these cells. 
Adult rat Schwann cells were isolated in a similar manner from sciatic nerves, and 
cultures of these cells contained approximately 20-25% contaminating fibroblasts. 
These cells were stained with anti-hSCF169, as shown in Figure 15 .  Approximately 
38% of the population exhibited fluorescence above control IgG levels, thus 
fibroblasts could not account for the entire SCF-expressing population. Moreover, 
Schwann cells can be separated from fibroblasts on the basis of their side scatter 
characteristics, as shown in Figure 16, which depicts a representative side scatter 
analysis of neonatal rat Schwann cells and 3T3 fibroblasts. Analysis of the adult rat 
Schwann cell cultures for fluorescence versus side scatter values was carried out to 
determine if the SCF-expressing cells in the adult rat Schwann cell cultures 
78 
Figure 12 
F ACS analysis for SCF expression by transfected rat Schwann cells. Transfected rat 
Scbwann cells were stained with a 1 : 10 dilution of rabbit anti-rhSCF169 polyclonal 
antiserum (light line), or a 1 : 10 dilution of pre-immune rabbit serum (dark l ine), 
counterstained stained with FITC-conjugated goat anti-rabbit IgG F(ab')2, and 
analyzed using an Epics 753 flow cytometer as described in Materials and Methods. 
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Figure 13  
FACS analysis for SCF expression by ST88-14 human schwannoma cells. ST88- 14 
cells were stained with a 1 : 10 dilution of rabbit anti-rhSCF169 polyclonal antiserum 
(dark line), or a 1 : 10 dilution of pre-immune rabbit serum (light line), counterstained 
stained with FITC-conjugated goat anti-rabbit IgG F(ab')2, and analyzed using an 
Epics 753 flow cytometer as described in Materials and Methods. 
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Figure 14 
F ACS analysis for SCF expression by neonatal rat schwann cells. Neonatal rat 
Scbwann cells were stained with a 1 :50 dilution of rabbit anti-rhSCF169 polyclonal 
antiserum (light l ine), or a 1 :50 dilution of pre-immune rabbit serum (dark line), 
counterstained stained with FITC-conjugated goat anti-rabbit IgG F(ab')2, and 
analyzed using an Epics 753 flow cytometer as described in Materials and Methods. 
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Figure 15 
FACS analysis for SCF expression by adult rat schwann cells. ARSC cells were 
stained with 50 1-'g/rnl rabbit anti-rhSCF169 polyclonal antiserum IgG fraction (solid 
line), or 50 �-tg/rnl rabbit IgG (dotted line), counterstained stained with FITC­
conjugated goat anti-rabbit IgG F(ab')2, and analyzed using a Becton-Dickinson 
F ACScan flow cytometer as described in Materials and Methods. 
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conformed to Schwann cell side scatter values. As shown in Figure 17 A, the majority 
of the cells which demonstrate a shift in fluorescence exhibit low side scatter values, 
similar to neonatal rat Schwann cells or the transfected rat Schwann cell line (Figure 
17B and C). In fact, the side scatter values for adult and neonatal rat Schwann cells 
are nearly identical. Therefore, we have concluded that both neonatal and adult rat 
Schwann cells produce membrane-bound SCF. 
Analysis of human Schwann cell cultures, which contained 40-50% Schwann 
cells, for SCF expression was carried out using an anti-nerve growth factor receptor 
(NGF-R) monoclonal antibody, which preferentially recognizes human Schwann cells. 
Light scatter analysis was again used to separate Schwann cells and fibroblasts 
(Figure 20A), and cells which showed an increase in fluorescence after staining with 
anti-NGF-R also exhibited a shift above background fluorescence after staining with 
anti-hSCF169 (Figure 20B and 20C). Thus, we have detected SCF expression, both 
in secreted and membrane-bound form, in several sources of rat Schwann cells, as 
well as normal human Schwann cells and a malignant human schwannoma cell 
line. 
V) c-kit Expression by Schwann Cells 
The expression of c-kit in cells known to produce SCF would indicate the 
possible use of an autocrine growth loop. Also, increases in c-kit expression have 
been noted in neoplastic phenomena such as acute myeloblastic leukemia (Lerner 
et al., 199 1 ), acute nonlymphocytic leukemia (Ikeda et al., 199 1 ), and small cell lung 
cancer (Sekido et al., 1991 ). Since SCF expression was noted inseveral sources of 
Schwann cells, we have examined these cells for production of the c-kit receptor 
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Figure 16 
Side scatter (SSC) analysis of neonatal rat Schwann cells (dark line) and 3T3 
fibroblasts (light line), as determined using an Epics 753 flow cytometer. 
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Figure 17 
Fluorescence- 1 (FITC) versus side scatter analysis of Schwann cells. Cells were 
analyzed for FITC fluorescence and side scatter values after staining with 50 �-tg/ml 
rabbit anti-rhSCF169 IgG fraction and FITC-conjugated goat anti-rabbit IgG F(ab'h 
using a Becton-Dickinson FACScan flow cytometer as described in Materials and 
Methods. Cell populations are (A) adult rat Schwann cells, (B) neonatal rat 
Schwann cells, and (C) transfected rat Schwann cells. 
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Figure 18 
F ACS analysis for SCF expression by normal human Schwann cells. A mixed 
population of fibroblasts and Schwann cells was stained with 50 J.Lg/ml rabbit anti­
rhSCF169 IgG fraction and a neat solution of mouse anti-human nerve growth factor 
receptor, or 50 J.Lg/rnl rabbit IgG and 15 J.Lg/rnl mouse I�G, counterstained with 
FITC-conjugated goat anti-rabbit IgG F(ab')2 and PE-conJugated goat anti-mouse 
IgG F(ab')2, and analyzed using an Epics 753 flow cytometer as described in 
Materials and Methods. A population of cells which demonstrated both FITC and 
PE fluorescence after staining with anti-rhSCF169 and anti-NGF-R was analyzed 
separately using light scatter properties and compared to a population of cells stained 
with control IgG-that had identical light scatter characteristics. 
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Figure 1 9  
RT-PCR to detect expression of c-kit rnRNA i n  ST88-14 human schwannoma cells. 
Total RNA was extracted from cells and subjected to RT-PCR as described in 
Materials and Methods, using primers specific for human c-kit, with an annealing 
temperature of 50°C for 30 cycles. Samples are {A) ST88- 14, (B) and (C) Human 
AML cells, and (D) Control, lacking RNA Arrowhead indicates expected 5 18 base 
pair PCR product. 
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Figure 20 
RT-PCR to detect expression of c-kit rnRNA in rat Schwann cells. Total RNA was 
extracted from (A) NRSC, (B) transfected rat Schwann cells, or (C) RBL-2H3 cells 
and subjected to RT-PCR as described in Materials and Methods, using primers 
specific for rat c-kit for 30 cycles with an annealing temperature of 50°C. Lane (D) 
is a control lacking RNA. Arrowhead indicates expected 976 base pair PCR product. 
tyrosine kinase. 
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RT-PCR using primers specific for human c-kit was able to amplify the 
expected 500 base pair band from ST88- 14 RNA, identical to the band detected from 
RNA extracted from two different sources of acute myelogenous leukemia cells 
(Figure 19), which are known to express c-kit (Lerner et a!., 1991). However, RT­
PCR amplification of RNA extracted from transfected rat Schwann cells or neonatal 
rat Schwarm cells failed to show expression of the expected 1000 nucleotide band 
(Figure 20), although these same preparations of RNA could be expanded using actin 
primers (Data not shown). 
To further examine the ability of Schwann cells to produce c-kit, anti-kit 
antibodies were used to stain and analyze Schwann cells by flow cytometry. Staining 
of the kit-expressing leukemic cell line M07E resulted in a large shift in fluorescence 
over control IgG (Figure 21) ;  however the small cell lung cancer line H146, which 
does not express c-kit message (Personal communication, Dr. Geoff Krystal, Medical 
College of Virginia), did not exhibit staining with this antibody (Figure 22). Normal 
human Schwann cells were labelled in a similar manner, and also showed no change 
in fluorescence (Figure 23), thus these cells do not appear to produce c-kit protein. 
However, the malignant schwannoma cell line ST88-14 did exhibit staining with anti­
kit antibody in several experiments (Figure 24). This result, together with the 
detection of c-kit message by RT-PCR, indicates that this tumor line produces not 
only SCF, but its receptor as well. 
Although no anti-rat c-kit antibodies were obtainable, the anti-human c-kit 
antibody YB5.B8 was found to cross-react with the rat c-kit protein, staining rat 
peritoneal mast cells (RPMC). However, this antibody did not successfully label 
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Figure 21  
F ACS analysis for expression of c-kit on human leukemic cells. M07E cells were 
stained with 20 J.'g/ml monoclonal mouse anti-human c-kit antibody YB5.B8 (dark 
line) or mouse IgG (light line), washed and counterstained with PE-goat anti-mouse 
IgG F(ab')2, then analyzed using an Epics 753 flow cytometer as described in 
Materials and Methods. 
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Figure 22 
FACS analysis for expression of c-kit on H 146 human small cell lung cancer cells. 
H 146 cells were stained with 15 �g/ml monoclonal mouse anti-human c-kit antibody 
(Boehringer) (dark line) or mouse IgG (light line), washed and counterstained with 
PE-goat anti-mouse IgG F(ab')2, then analyzed using an Epics 753 flow cytometer as 
described in Materials and Methods. 
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Figure 23 
F ACS analysis for expression of c-kit on normal human Schwann cells. HSC cells 
were stained with 20 1-'g/rnl monoclonal mouse anti-human c-kit antibody YB5.B8 
(solid line) or mouse IgG (dotted line), washed and counterstained with PE-goat anti­
mouse IgG F(ab')2, then analyzed using a Becton-Dickinson FACScan flow cytometer 
as described in Materials and Methods. 
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neonatal rat Schwann cells, the transfected rat Schwann cell line, or adult rat 
Schwann cells (Data not shown). These data correlate with the RT-PCR results 
above. Thus, of the Schwann cells examined, only the malignant schwannoma cells 
appear to express c-ldt. Experiments aimed at slowing the proliferation of ST88-14 
cells using anti-SCF or anti-kit antibodies, as well as anti-sense c-ldt oligonucleotides 
have not been fruitful, but the use of an autocrine growth loop by these cells has not 
been excluded. Table I summarizes the extent of SCF and c-Kit expression by the 
Schwann cells examined in this study. 
V) Production of SCF by the MMC-34 Mast Cell Line 
Mast cells have been shown to produce an array of cytokines that roughly 
correlates to the TI-12 subset of T lymphocytes (Plaut et al., 1989). Following from 
the work of this and other laboratories which has shown the importance of SCF in 
mast cell development and function, we sought to determine if mast cells also could 
produce SCF. Several mast cell lines were initially investigated for SCF gene 
expression using RT-PCR. These included PT- 18, P815, and MMC-34. Of these, 
only MMC-34 reproducibly exhibited expression (Figure 25A). Although RT-PCR 
is not normally employed for quantitative measurements, relative expression of the 
expected 600 nucleotide SCF band increased after incubation of MMC-34 cells with 
PMA, as compared to the 500 nucleotide actin band (Figure 25B). 
As described above, SCF can be produced as either a membrane-bound or 
secretable growth factor (Flanagan et al., 1991). To determine if MMC-34 mast cells 
produce the secreted form of SCF, the conditioned medium was concentrated 50 fold 
on an Arnicon YM-10 membrane and placed in our committed progenitor assay in 
the presence or absence of blocking antibodies to IL-3. The use of these antibodies 
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Figure 24 
FACS analysis for expression of c-kit on ST88- 14 human Schwannoma cells. ST88- 14 
cells were stained with 15  JLg/rnl monoclonal mouse anti-human c-kit antibody 
(Boehringer) (light line) or mouse IgG (dark line), washed and counterstained with 
PE-goat anti-mouse IgG F(ab'h, then analyzed using an Epics 753 flow cytometer as 
described in Materials and Methods. 
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Table I 
Summary of SCF and c-kit Expression by Schwann Cells 
Scbwann Cell Type SCF Expression c-kit Expression 
Neonatal Rat + + + +  -
Adult Rat + + +  -
Transfected Rat + + +  -
Normal Human + + +  -
Human Schwannoma + + +  + +  
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Figure 25 
RT-PCR to detect mSCF and actin expression in mast cells. Total RNA was 
extracted and subjected to RT-PCR with an annealing temperature of 50°C for 30 
cycles using primers specific for (A) mSCF or (B) actin as described in Materials and 
Methods. Samples are ( 1 )  BALB/c 3T3, (2) MMC34, (3) MMC34 + 50ng/rnl PMA, 
(4) P3Ag8.653, (5) P3Ag8.653 + 50ng/ml PMA (6) Control (-RNA). Arrowhead 
indicates the expected sizes of the PCR products. 
A 
8 
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was necessary, as mast cells have been shown to produce IL-3 (Plaut et al., 1989), 
and RT-PCR of MMC-34 RNA using primers for IL-3 message showed the presence 
of the expected 550 base pair (Figure 26). As shown in Figure 27, MMC-34-CM was 
able to generate up to 70 mast cell colonies from Nb-MLN cells in the presence of 
the anti-IL-3 antibody. Inhibition of recombinant IL-3 and PWM-SCCM activity was 
significantly more effective than inhibition of MMC-34-CM. Since SCF is known to 
synergize with IL-3 (de Vries et al., 199 1 ), the blocking of IL-3 could be expected to 
decrease the activity of SCF in these cultures. 
Mast cell phenotype is known to be dependent upon the microenvironment 
in which the cells differentiate (See Literature Review), and as supported by the 
above data, SCF can induce a CTMC phenotype from committed progenitors, while 
sources of IL-3, such as PWM-SCCM cannot. Therefore, we examined the phenotype 
of mast cells generated from stimulation with MMC-34-CM, using the rationale that 
if SCF were present in mast cell-conditioned medium, it might induce a connective 
tissue phenotype in newly generated mast cells. While 8 1 %  or 95% of cells derived 
from cultures stimulated with MMC-34-CM or 31'3 FCM, respectively, stained with 
safranin, cells stimulated with PWM-SCCM did not. Similar results were obtained 
with berberine sulfate staining, where no PWM-SCCM-stimulated cells were stained, 
but 98% of 31'3 FCM-stimulated and 10% of MMC-34-CM-stimulated cells were 
stained (Table II). Thus, Nb-MLN cells could be stimulated by MMC-34-CM to form 
colonies containing CTMC, indicative of SCF present in this conditioned medium. 
Staining of MMC-34 mast cells with an antibody made against rmSCF169 was 
used to determine the extent of surface-bound SCF expression. As shown in Figure 
28, MMC-34 cells could be stained with this antibody above similar dilutions of pre 
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Figure 26 
RT-PCR to detect IL-3 mRNA expression in MMC34 mast cells. Total RNA was 
extracted and subjected to RT-PCR with an annealing temperature of sooc for 30 
cycles using primers specific for rodent IL-3. Samples are (A) MMC34, (B) Control 
(-RNA), and (C) WEHI-3 cells. Arrowhead indicates the expected 547 base pair 
PCR product. 
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Figure 27 
Activity of MMC34-CM in committed progenitor assay. Nb-MLN cells were cultured 
for 13 days in the presence of SOX MMC34-CM ± 20J.tg/ml anti-IL-3 antibody 
(diagonal-striped and open boxes, respectively), 200 u/ml recombinant mouse IL-3, 
or 10% v jv PWM-SCCM ±20 J.tg/ml anti-mouse IL-3 antibody (filled and horizontal­
striped boxes, respectively). Controls are 3T3-CM and medium alone (stippled 
boxes). Values represent mean colony numbers and standard errors from two wells 
of a 24 well plate in one of two representative experiments. 
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Table II 
Phenotype of Cells Derived from Culture of Nb-MLN Cells with MMC-34-CM 
Stimulus Toluidine Blue Berberine Safranin 
(Histamine) Sulfate (Heparin) 
(Heparin) 
MMC34-CM 99% 10% 81% 
3T3 FCM 98% 98% 95% 
PWM-SCCM 100% 0% 0% 
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Figure 28 
Staining of MMC-34 mast cells for SCF expression. MMC-34 cells were stained with 
a 1 : 10 dilution of rabbit anti-rrnSCF169 or a 1 : 10 dilution of pre-immune rabbit serum 
and counterstained with goat anti-rabbit IgG F(ab')2, then analyzed on an Olympus 
BH2-NIC fluorescent microscope. (A) Photomicrograph of MMC-34 cells under ( 1 )  
normal, and (2) fluorescent light. (B) Percentage of  MMC-34 or  P3Ag8.653 
(negative control) cells exhibiting fluorescence after staining with antibody or control 
serum. 
B Anti-SCF Staining of MMC-34 Mast Cells 
Cells 
MMC-34 + Anti-mSCF169 
MMC-34 + Preimmune Serum 
P3Ag8.653 + Anti-mSCF169 
P3Ag8.653 + Preimmune Serum 
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Percent Fluorescent 
78% 
12% 
0% 
17% 
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-immune control serum levels, and the antibody failed to stain P3Ag8.653 cells, which 
do not express SCF message, as determined by RT-PCR (Figure 25). However, this 
staining was dim, and quenched quickly, even in the presence of sodium azide. Flow 
cytometric analysis of these cells under similar conditions gave contrasting results. 
No notable change in fluorescence was detected in unstimulated cells, and only a 
small shift in fluorescent intensity was detected after PMA stimulation (Figure 29A 
and 29B). 
VI) The Peritoneal Mast Cell Progenitor 
The committed progenitor assay exploits a local mastocytosis that occurs in 
the MLN during Nb infection. However, mast cell progenitors are present in other 
locations, and Nb infection may influence these progenitors as well. To determine 
what effect Nb infection has on peritoneal mast cell progenitors, peritoneal cells were 
extracted from mice on various days after infection, and cultured in methylcellulose 
under conditions similar to the committed progenitor assay. Peritoneal cells 
extracted from naive mice formed many mast cell colonies in response to stimulation 
with 3T3 FCM, as did cells extracted on day 3 after infection. Unexpectedly, cells 
harvested on days 5, 8, 1 1 , 14 or 17 yielded essentially no mast cell colonies after 
stimulation with 3T3 FCM (Table III). A similar pattern of response was noted 
using recombinant mSCF169, which stimulated the formation of 409 colonies from 
naive mice, but none on day 14 after infection (Table IV). Responsiveness seemed 
to return gradually 30-45 days after infection, although this has not been studied in 
detail (Data not shown). Thus Nb infection appears to have a dramatic negative 
effect on peritoneal mast cell precursors. 
To characterize the peritoneal mast cell precursor population, peritoneal cells 
1 19 
Figure 29 
FACS analysis of (A) unstimulated or (B) PMA-stimulated (50ng/rnl, 60 minutes) 
MMC-34 mast cells for surface expression of mSCF. MMC-34 cells ± 50 ng/rnl 
PMA were stained with 20 J.tg/ml rabbit anti-rmSCF169 polyclonal antiserum IgG 
fraction (solid line) or 20 llgfml rabbit IgG (dotted line), counterstained with FITC­
goat anti-rabbit IgG, and analyzed with a Becton-Dickinson FACScan flow cytometer. 
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Table III 
Time Course of Peritoneal Mast Cell Progenitor Response to 3T3 FCM 
Day of Infection Colonies in Response to Colonies in Response to 
15x 3T3-CM ± SEM Medium 
Day 0 362 ±35.5 0 
Day 5 629 ±36.0 0 
Day 8 0 0 
Day 1 1  0 0 
Day 14 0 0 
Day 17 0 0 
Nb-MLN Day 14 139 ± 18.2 0 
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from naive mice were separated on a discontinuous percoll gradient. Tables V shows 
the results of this preliminary experiment. While fraction 4 contained the highest 
percentage of mature mast cells (99%), fraction 3, which contained only 5% mature 
mast cells could be induced by 3T3 FCM to yield almost four times as many mast 
cell colonies as fraction 4 (84 versus 23, respectively). The density of cells in fraction 
3 was 1 .072- 1 .082 g/ml, which is slightly higher than the 1 .060- 1 .070 g/rnl density of 
the MCCP (Jarboe et al., 1989). The failure of the mast cell-colony forming activity 
to segregate with fraction 4 implies that mature peritoneal mast cells do not account 
for the entire proliferative capabilities found in the peritoneal mast cell population. 
Therefore a nongranulated, SCF-responsive mast cell progenitor appears to be 
present in the peritoneal cavity as well as the Nb-MLN. 
Separation of peritoneal cells from 14 day Nb-infected mice gave results which 
contrasted with those derived from naive mice. As shown in Table VI, unseparated 
peritoneal cells from Nb-infected mice gave no mast cell colonies in response to 3T3 
FCM. The same result was obtained with cells that had a density below 1 .082, which 
includes the 3T3 FCM-responsive cells found in the naive peritoneal cavity. 
Unexpectedly, peritoneal cells from Nb-infected mice that had a density greater than 
1 .082 generated 40 mast cell colonies in response to 3T3 FCM. These cells were 
composed of 12.3% mature mast cells, and many small blast cells. The ability of this 
fraction and not unseparated or lower density cells to respond to 3T3 FCM implies 
that an active form of inhibition may be occurring among the other fractions tested. 
VII) Production of SCF by Placental Tissues 
As our early work on SCF expression became known among investigators in 
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Table IV 
Time Course of Peritoneal Mast Cell Progenjtor Response to SCF 
Cell Population Stimulus Mast Cell Colonies 
± SEM 
Naive Peritoneum 50 ng/ml rmSCP69 409 ±25.0 
Medium 0 
Day 14 Nb-Peritoneum 50 ng/ml rmSCF169 0 
Medium 0 
Day 14 Nb-MLN 50 ng/ml rmSCF169 162 ±35.0 
Medium 0 
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Table V 
Percoll Density Separation of Peritoneal Mast Cell Progenitors from Naive Mice 
Cell Source Stimulus Colonies x % Mast Percent Mast Cells at 
Cells ± SEM Day O 
Unseparated 31'3 FCM 257 ± 45.2 2.2% 
Peritoneum 
Medium 0 
Frac.l < 1 .062 g/ml 31'3 FCM 34 ± 0.25 4% 
Medium 0 
Frac.2 1 .062-1 .072 g/ml 31'3 FCM 22 ± 0.35 1 %  
Medium 0 
Frac.3 1 .072-1.082 g/ml 31'3 FCM 84 ± 6.0 5% 
Medium 0 
Frac.4 > 1 .082 g/ml 31'3 FCM 23 ± 1.5 99% 
Medium 0 
Nb-MLN 31'3 FCM 80 ± 6.0 
Medium 0 
Table VI 
Percoll Density Separation of Peritoneal Mast Cell Progenitors 
from Nb Infected Mice 
Colonies X % Mast 
Cell Source Stimulus Cells ± SEM 
Unseparated 3T3 FCM 0 
Peritoneum 
Medium 0 
Frac. 1 < 1 .082 3T3 FCM 0 
Medium 0 
Frac. 2 > 1.082 3T3 FCM 4Q ± 5.0 
Medium 0 
Nb-MLN 3T3 FCM 80 ± 6.0 
Medium 0 
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Percent Mast 
Cells at Day 0 
2.2% 
2.0% 
12.3% 
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our area, we were approached by Dr. Scott Kauma, Department of Obstetrics and 
Gynecology, Medical College of Virginia, with questions concerning cytokine 
production by placental tissues. In the course of these discussions, we suspected that 
SCF may play a role in placental growth and fetal hematopoiesis. As a result, Dr. 
Kauma agreed to provide us with RNA extracted from human, rat, or mouse 
placental tissues, with the purpose of detecting SCF message in these tissues. Initial 
experiments using RT-PCR demonstrated the expression of the expected 830 
nucleotide band in many of the placental tissues examined, as is summarized in Table 
VII. However, the sensitivity of RT-PCR left concerns about contaminating tissue 
unanswered, and quantitative results could not be obtained. Therefore we employed 
northern analysis to detect SCF transcripts. Northern blot of rat placental tissues 
shows a prominent band at 6.5 kb (Figure 30), the expected size for SCF (Anderson 
et al., 1 990; Zsebo et al., 1990; Matsui et al ., 1990). There was notable variability 
in the levels of SCF expression, with endometrium and placenta showing strong 
bands, while decidual tissues had little or no expression. Expression also appeared 
to increase from day 15 to day 18 in the placenta. By contrast, human tissues 
appeared to express a 6. 1 kb band in low quantities; in fact this SCF message was 
only detectable in human placenta after selection of polyadenylated RNA (Figure 
3 1  ). Thus SCF RNA is expressed in several of the rodent reproductive tissue 
examined, but appears to be expressed at lower levels in equivalent human tissues. 
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Table VII 
RT-PCR Analysis of SCF Expression by Human Reproductive Tissues 
Cell Source Stem Cell Factor Expression 
111 Trimester Placenta + + + +  
1 "1 Trimester Decidua + + + +  
111 Trimester Trophoblasts + + +  
1 .. Trimester Villous Core 0 
Term Placenta + + +  
Term Trophoblasts 0 
Term Villous Core + +  
Term Placental Membranes + + +  
Proliferative Endometrium + +  
Secretory Endometrium + + +  
128 
Figure 30 
Northern analysis of human placenta for SCF expression. Northern blot of human 
(A) term placental polyadenylated RNA and (B) term placental total RNA probed 
with a 32P-labelled 539 nucleotide human SCF eDNA Arrowheads indicate 28s and 
18s ribosomal bands. 
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Figure 3 1  
Northern analysis for expression of SCF message i n  rat reproductive tissues. (A) 
Northern blot of total RNA from rat ( 1) endometrium, (2) 15 day decidua, (3) 18 day 
decidua, (4) 15 day placenta, and (5) 18 day placenta probed with a 32P-Iabelled 539 
nucleotide human SCF eDNA Arrowheads indicate 28s and 1 8s ribosomal bands. 
(B) Ethidium bromide staining of 1 %  formaldehyde-agarose gel in (A) to show equal 
loading of samples. 
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B. 
Discussion 
I) Effect of rmSCF on Mast Cell-Committed Progenitors 
Stem cell factor has proven to be important in many facets of mast cell 
biology, including proliferation (Jozaki et al., 1991), differentiation (Williams et al., 
1992), migration (Meininger et al., 1992), and activation (Bischoff and Dahinden, 
1992; Nakajima et al., 1992; Wershil et al., 1992). Although this growth factor cannot 
induce mast cell formation from bone marrow progenitors, it acts on many later 
stages of the lineage, including bone marrow culture-derived mast cells, and fully 
mature peritoneal mast cells. The mapping of SCF to the Steel locus and its 
identification as the c-ldt ligand have proven what many investigators have long 
suspected: the pleiotropic abnormalities associated with mutations at the W or S/ loci 
are due to a growth factor-receptor interaction. 
We have sought to determine the ability of SCF to induce mast cell colony 
formation from the mast cell-committed progenitor. This committed progenitor is 
poised at the stage of granulation, and can respond to either IL-3 or FCM (Jarboe 
et al., 1989). While the committed progenitor offers a well focused window for the 
study of mast cell differentiation, the signals required for this differentiation still had 
not been fully elucidated. This laboratory has previously shown the ability of 3T3 
FCM to induce mast cell colony growth from committed progenitors, but the identity 
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of the fibroblast growth factor remained unknown. With the cloning of SCF came 
the finding that 3T3 fibroblasts produce this growth factor (Flanagan and Leder, 
1990). We therefore tested to determine if recombinant SCF could mimic the effect 
of 3T3 FCM on committed progenitors and found that it could (Figure 3). 
In fact, while an average of 90 mast cell colonies per well were generated in 
response to 3T3 FCM, as much as 1 10 colonies per well were induced by rmSCF. 
This result indicates that SCF alone is capable of mimicking the effect of 3T3 FCM, 
and may in fact be a more potent proliferative signal. This maximal response of 
rmSCF alone on colony formation stands in contrast to a minimal colony forming 
activity of rmSCF on bone marrow stem cells. Several investigators have shown that 
SCF acts more as a co-factor in concert with IL-3 or IL-6 to promote CFU-GEMM 
(de Vries et al. , 1991) .  The ability of SCF alone to promote maximal proliferation 
of mast cell-committed progenitors may be important in the natural differentiation 
of mast cell-committed progenitors as they leave the bone marrow for fibroblast-rich 
sites such as derrnis, which lack IL-3. 
Two phenotypes of mast cells are known to exist in the mouse: connective 
tissue and mucosal. These cells differ in their in vivo location, size, life span, 
dependence upon IL-3, and granule contents. The difference in granule contents can 
be indicated by staining methods to differentiate between the two mast cell 
phenotypes. CTMC, but not MMC contain heparin proteoglycan. This proteoglycan 
can be detected by staining with either safranin or berberine sulfate. Figure 5 shows 
that mast cells derived from cultures stimulated with rmSCF or 3T3 FCM, but not 
PWM-SCCM exhibited CTMC phenotype by these staining criteria. The difference 
in berberine sulfate staining between 3T3 FCM and rmSCF-stimulated cells (98% 
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versus 63% respectively) has not been explained, although it could relate to a 
difference in "critical electrolyte concentration" (CEC) that exists between the two 
groups of cells. The CEC is determined by a cell's granule contents, and a minimum 
CEC is required for staining with berberine sulfate or safranin  (Bernstein and 
Lawrence, 1990). However, this would not explain the very similar values obtained 
for safranin staining of 3T3 FCM versus rmSCF-stimulated cells (95% and 98% 
respectively). Overall, rmSCF seems to be able to promote a transition to a 
connective tissue phenotype. 
Mast cell colonies induced by rmSCF were consistently larger than those 
cultured with FCM (Figure 4). While FCM stimulated formation of colonies with 
about 100 cells each, rmSCF generated colonies of 500 cells or more. These 
differences may be due to the proliferative signalling capacity of the two growth 
factors, i.e. rmSCF may be more mitogenic at the doses used, solely because it 
contains more SCF than FCM. Another possibility is that FCM and rmSCF 
stimulate different subsets of mast cell progenitors, as has been described for 
peritoneal mast cell precursors (Kanakura et al., 1988). Kanakura, et al. described 
the proliferative capabilities of three mast cell progenitors, stating that small (S)­
CFU-Mast gave colonies containing fewer than 32 cells, while medium (M)-CFU­
Mast yielded colonies with 32-499 cells, and large (L)-CFU-Mast resulted in colonies 
of greater than 500 cells each (Kanakura et al., 1988). While these subsets were 
examined in the peritoneal cavity, the authors hypothesize them to be a part of the 
normal mast cell lineage. Thus it could be argued that rmSCF acts on L-CFU-Mast, 
while 3T3 FCM stimulates M-CFU-Mast. However, we feel this is not a likely 
possibility for two reasons: First, colony size was directly dependent upon the 
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concentration of rmSCF with which the cells were stimulated. Lower concentrations 
of rmSCF not only yielded fewer colonies, but these colonies contained fewer cells 
as well. Second, the degree of differentiation seen by Kanakura, et al. varied with 
the progenitor subset stimulated. While S- or M-CFU-Mast yielded mast cells which 
stained with berberine sulfate, L-CFU-Mast did not. In our cultures this effect was 
not noted. As shown in Figure 5 ,  mast cells derived from culture with rmSCF stained 
with berberine sulfate, as well as safranin. In fact, higher doses of SCF generally 
yielded greater percentages of mast cells capable of staining with these dyes (Data 
not shown). 
We conclude that rmSCF induces both mast cell proliferation and 
differentiation to the CfMC phenotype from Nb-MLN cells, and that the increased 
colony size associated with rmSCF culture is due to greater proliferative capabilities 
possessed by this factor, rather than the stimulation of distinct mast cell subsets by 
rmSCF and 3T3 FCM. 
II) SCF and Kit Production by Schwann cells 
Mast cells are associated with normal nerves (Bienenstock et al., 1991), 
increase in nerve damage and repair (Isaacson, 1976; Olsson, 197 1), and are 
hyperplastic in neoplastic phenomena that involve Schwann cells such as 
neurofibromas and schwannomas (Isaacson, 1976). Schwann cells are associated with 
peripheral nerves, functioning in myelination and nerve regeneration and repair. 
Therefore, it seemed logical to hypothesize a role for Schwann cells in neuron­
associated mast cell hyperplasia. The role of SCF in mast cell development made 
it an ideal target for this hypothesis, thus we sought to examine the ability of rat and 
human Schwann cells to produce this growth factor. Through the kind gift of Dr. 
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Cynthia Morton (Brigham and Women's Hospital, Harvard), we obtained a malignant 
human schwannoma cell line, derived from the peripheral nerve of a 
neurofibromatosis patient. We also obtained a rat schwann cell line derived by SV40 
large T antigen induction of neonatal Schwann cells from the laboratory of George 
DeVries, Virginia Commonwealth University. 
As is shown in figure 6, RT-PCR of total RNA extracted from either Schwann 
cell line demonstrated the expression of SCF message, as determined by the presence 
of the expected 830 base band. Having determined that both cell lines express SCF 
message, these cells were then examined for the production of SCF protein. 
Concentrated transfected rat Schwann cell-CM placed in the committed progenitor 
assay (Figure 7) induced mast cell colony formation from Nb-MLN cells in a dose­
responsive manner, and was comparable to 3T3 FCM. Of the known growth factors 
tested {Appendix A and Literature Review), only IL-3 has been active in this assay. 
However, RT-PCR for IL-3 expression failed to detect a band corresponding to IL-3 
from transfected rat Schwann cell RNA in several experiments (Figure 8). Because 
these cells do not make IL-3, but conditioned medium from this cell line is active in 
the committed progenitor assay, we conclude that transfected rat Schwann cells 
produce secretable SCF which is active on mast cell progenitors. 
Concentration of ST88- 14 human schwannoma CM did not yield similar 
results. Use of this supernatant in a proliferation experiment with the SCF­
dependent leukemic cell line M07E was not able to support proliferation (Figure 
1 1) .  This experiment was repeated several times and used multiple concentrations 
of ST88-14  CM. This result may be due to a selective formation of membrane-bound 
SCF, rather than soluble. Previous reports have shown that two transcripts for SCF 
137 
are generated by alternative splicing (Flanagan et al., 199 1) .  One of these, KL-1 
encodes the full length SCF molecule, while the other, KL-2, encodes a truncated 
form lacking the membrane tether region. Expression of KL-1 results in the 
production of a SCF protein with a proteolytic cleavage site that is hypothesized to 
yield secreted SCF. Expression of KL-2 results in the production of membrane­
bound SCF only. Fujita and Kitamura have shown that such differential splicing may 
be used to phenotypically divide two cell lines as similar as BALB/c 31'3 fibroblasts 
and NIH 31'3 fibroblasts (Fujita and Kitamura, 1991 ). Thus it is possible that the 
transfected rat Schwann line produces predominantly KL-1 ,  while ST88- 14  cells make 
predominantly KL-2. 
To determine if some or all Schwann cells do express SCF on their surface, 
a polyclonal rabbit anti-SCF169 antibody produced in our laboratory was used. A 
human fibrosarcoma cell line, HT1080, which produces SCF, could be stained with 
this antibody, but not pre-immune serum, an this antibody failed to stain the human 
small cell lung cancer cell line H5 10, which does not express SCF. Transfected rat 
Schwann cells stained with anti-SCF169 also demonstrated a shift in fluorescence 
relative to control serum when analyzed by flow cytometry. This indicates that these 
cells produce membrane-bound SCF in addition to the secreted SCF detected in the 
committed progenitor assay. This result is consistent with the expression of KL-1 
hypothesized above. Normal neonatal rat Schwann cells also exhibited SCF 
expression by flow cytometric analysis, as did adult rat Schwann cells. This indicates 
that SCF expression by transfected rat Schwann cells is most probably not a function 
of SV40 transfection. More interestingly, the malignant human schwannoma ST88-
14, which did not have SCF activity in its conditioned medium, also exhibited a 
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notable shift in fluorescence with anti-SCF169 staining versus pre-immune serum, 
indicating membrane-bound SCF. SCF was also detected on the surface of normal 
adult human Schwann cells, indicating that SCF expression by ST88- 14 cells is 
probably not due to malignant transformation. Because all Schwann cells analyzed 
have demonstrated expression of SCF, we have concluded that SCF production is a 
normal facet of Schwann cell biology. 
The consistent production of SCF by Schwann cells could explain the 
remarkable mast cell hyperplasia observed in many neurofibrotic lesions. A large 
scale increase in the number of Schwann cells would result in much higher local 
concentrations of SCF. This would result in local mast cell hyperplasia, which is the 
case. Indeed, pharmacologic agents active on mast cells (e.g. ketotifen) have proven 
to be efficacious in the clinical treatment of this syndrome (Riccardi, 1987). An 
alternative question which has not been addressed in this work is whether any of the 
many cytokines known to be produced in large quantity by mast cells may actually 
amplify the proliferation of Schwann cells in these lesions. Also not addressed in this 
work is the role of Schwann cell-produced SCF in the development of the nervous 
system. Since SCF and c-ldt have both been shown to be expressed in the embryonic 
mouse nervous system during development (Keshet et al., 199 1 ), it is possible that 
SCF produced by Schwann cells may regulate neuron growth or function. In fact, 
preliminary experiments have demonstrated strong expression of c-ldt protein on the 
surface of neonatal rat neurites in culture (Neuberger and DeVries, personal 
communication), indicating that stimulation of neurons by SCF may be possible. 
Since the receptor for SCF, c-ldt, has been linked to AML (Lerner et al., 
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199 1 ), ANLL (Ikeda et al., 1991), and small cell lung cancer (Sekido et al. ,  1991), 
and since production of both a growth factor and its receptor would make possible 
the use of an autocrine growth factor loop, we sought to determine if Schwann cells 
produce c-kit. RNA isolated from ST88- 14, transfected rat Schwann, or neonatal rat 
Schwann cells was analyzed by RT-PCR to detect c-kit message. While the malignant 
ST88- 14 cells express c-kit message, it could not be detected in transfected rat 
Schwann cell and neonatal rat Schwann cell RNA, even on long exposures. These 
same preparations could be amplified by RT-PCR using actin primers. From these 
results it appears that ST88-14 cells express c-kit message, while normal or SV40-
transfected neonatal rat Schwann cells do not. 
To determine the extent of cell surface expression of the c-kit protein, these 
different Schwann cells were stained with a monoclonal mouse anti-human c-kit 
antibody, and counterstained with PE-goat anti-mouse IgG. Although this antibody 
was able to stain purified rat peritoneal mast cells, which express c-kit, no staining 
of either transfected rat Schwann cells or neonatal Schwann cells was detected. 
Coupled with the RT-PCR data, this result makes it apparent that these Schwann 
cells do not express c-kit. Similarly, normal adult human Schwann cells did not 
exhibit c-kit expression, although these cells were only evaluated in one experiment. 
However, the malignant schwannoma did show a shift in fluorescence, indicative of 
c-kit expression by this cell line. Thus while normal Schwann cells do not appear to 
produce the c-kit receptor tyrosine kinase, the malignant schwannoma does. This 
apparently aberrant expression of a protooncogene, in the presence of its ligand, 
could lead to the use of an autocrine growth loop by these cells. We have attempted 
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to investigate this possibility through the use of anti-sense oligonucleotides and 
antibodies against SCF and c-kit, however none of these agents has yet been able to 
consistently reduce the proliferation of this tumor line (Data not shown), although 
we have not ruled out this possibility. 
In summary, normal Schwann cells produce SCF, and a malignant human 
schwannoma also produces not only this growth factor, but also the receptor for SCF, 
c-kit, which is not expressed on normal Schwann cells. The expression of both the 
ligand and its receptor could constitute an autocrine loop in this cell line, which may 
reflect the etiology of some NF-related malignant schwannomas. 
III) Production of SCF by a Mast Cell Line 
The ability of mast cells to produce cytokines has recently been shown (Plaut 
et al., 1989), allowing new insight into the role of mast cells in inflammation and 
immunoregulation. Since mast cells have been shown to produce such a wide array 
of growth factors, and SCF plays an important role in mast cell development, it is 
logical to hypothesize that mast cells may be able to produce SCF. To examine this 
possibility, we extracted RNA from the mast cell lines PT-18, MMC-34, and P815.  
SCF message could be amplified only from unstimulated MMC-34 mast cells. 
Expression appeared to increase after activation with the phorbol ester PMA. 
Although RT-PCR is not designed to give quantitative results, the increase in band 
intensity was obvious, while actin expression remained unchanged. These results 
agree with the data of Plaut, et al. (Plaut et a!., 1989), who showed increased 
production of cytokines by mast cells after stimulation with phorbol esters and 
calcium ionophores. Thus MMC-34 mast cells express message for SCF, and appear 
to upregulate expression after activation with PMA. 
141  
To detect secreted SCF made by this cell line, a 50 fold concentrate of  MMC-
34-CM was tested in the mast cell-committed progenitor assay. Since mast cells 
produce IL-3, and MMC-34 mast cells expressed detectable IL-3 message by RT­
PCR, the conditioned medium was incubated with a blocking antibody against IL-3 
prior to using the conditioned medium in the cultures. MMC-34-CM was able to 
support mast cell colony development, even in the presence of blocking anti-IL-3 
antibodies, from committed progenitors, although the proliferative capabilities of 
MMC-34-CM were less than that of 3T3-CM. Since SCF has been shown to be 
synergistic with many growth factors, including IL-3 (de Vries et al., 1991), we 
anticipated some inhibition of MMC-34-CM activity in the assay and there was some, 
although the inhibition seen was substantially less than that found in cultures of riL-3 
or PWM-SCCM. Thus this mast cell line apparently produces a mast cell growth 
factor other than lL-3. Although mast cells have not been reported to produce NGF, 
it is known that NGF can synergize with IL-3 to induce mast cell development from 
progenitors (Matsuda et al., 1991). However we do not feel that NGF is the active 
growth factor in MMC-34-CM, due to the presence of SCF message in MMC-34 
RNA. Moreover, NGF is unable to support mast cell proliferation alone and was not 
active in the committed progenitor assay (Matsuda et al., 199 1 ;  Jarboe et al., 1989). 
Therefore it appears unlikely that NGF would be active in this system in the 
presence of anti-IL-3 antibodies. 
While IL-3 alone can support the development of mucosal mast cells, it is 
unable to generate connective tissue mast cells in the committed progenitor assay 
(Jarboe et al., 1989). Cells derived from culture of Nb-MLN cells with MMC-34-CM 
were determined to have a connective tissue phenotype, based on staining with 
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safranin and berberine sulfate. Mast cells derived from culture with PWM-SCCM, 
a source of IL-3, did not. The difference in proportions of cells staining with 
berberine sulfate in cultures stimulated with MMC-34-CM was substantially less than 
those stimulated with 3T3-CM, but was more similar to that obtained with 
stimulation of Nb-MLN cells with recombinant SCF. The most important distinction 
is that any of the cells change phenotype, which may indicate the presence of SCF, 
in concentrations however small. The results with MMC-34-CM and the results with 
recombinant SCF are similar to those reported by Tsai and Galli, who showed that 
recombinant SCF injected into rats could enhance the proliferation of dermal 
connective tissue phenotype mast cells (Tsai and Galli, 1991) .  
We then employed anti-mSCF169 antibodies to detect surface expression of 
SCF on MMC-34 mast cells. Immunofluorescent microscopy analysis showed that 
MMC-34 cells were stained above background levels with this antibody, however this 
staining was dull and quenched quickly. However, flow cytometric analysis of MMC-
34 cells stained in a similar manner gave contrasting results. Unstimulated MMC-34 
cells demonstrated no shift in fluorescence after staining with anti-rmSCF169, although 
PMA stimulation of these cells resulted in a small shift in fluorescence intensity. 
Thus these cells appear to produce little surface-bound SCF, and the increase in SCF 
message correlated with an increase in surface SCF. 
We conclude from these results that the MMC-34 mast cell line expresses 
SCF, probably of the KL-1 type, given the detectable SCF in conditioned medium 
from this cell line and weak surface staining of these cells for SCF. The production 
of SCF may not be a normal facet of mast cell biology, however, since of the four 
cell lines examined, only MMC-34 cells have shown SCF production. 
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IV) Effect of Nb Infection on Peritoneal Mast Cell Progenitors 
The mast cell-committed progenitor is present in the Nb-MLN, but not naive 
MLN, indicating that Nb infection enhances mast cell progenitor populations in the 
region of the infection (Jarboe et al., 1989). The progenitor can be generated from 
naive bone marrow after stimulation with conditions mimicking the 
microenvironment of the MLN during infection (Ashman et al., 199 1 ). The 
committed progenitor is believed to be derived from a bone marrow-derived 
progenitor cell, which trafficks to the MLN due to Nb infection (Ashman et al., 
1991) .  These studies lead our laboratory to questions about the possible effects of 
Nb infection on mast cell progenitor populations in other areas. To approach this 
question, cells in the peritoneal cavity were harvested at various times after infection 
and were tested for their ability to function as mast cell progenitors. While mast cell 
colonies could be induced from peritoneal cells at days 0 and 5 of Nb infection, the 
ability of these cells to function as mast cell progenitors was completely absent at day 
8, and the cells remained nonresponsive through day 17. In two separate 
experiments, cells cultured at days 47 and 9 1  after infection were again responsive 
to 3T3 FCM, yielding colony numbers that were 33% and 96% of Day 0 values, 
respectively (Data not shown). The loss of progenitor activity was not due to a 
dilution of the progenitor population by the influx of cells which occurs in the 
peritoneal cavity during Nb infection. Although peritoneal cell numbers increased 
6.25 ± 1 .43 fold from day 0 to day 14 of infection, increasing the number of peritoneal 
cells plated in methylcellulose to account for the increased cell numbers had no 
effect on progenitor development from the Nb-infected peritoneal cavities (Data not 
shown). 
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The mast cell progenitor found in the peritoneal cavity was found to respond 
to rmSCF169 in addition to FCM. Moreover, the pattern of response is similar to that 
observed with FCM during Nb infection: while day 0 peritoneal cells yield 404 
colonies, day 14 cells gave none. Therefore this dramatic contrast in mast cell 
progenitor responsiveness during Nb infection can be reproduced with rmSCF169 
stimulation. 
Naive peritoneal cells were separated by density using percoll and assayed for 
FCM responsiveness. Day 0 cells exhibited responsiveness to FCM over a range of 
densities, however the most responsive fraction was cells with a density of 1 .062-
1.072. This data is important for two reasons. First, it demonstrates that mast cell 
colonies derived from culture of these cells with FCM are not due solely to the 
proliferation of mature mast cells. The greatest percentage of mast cells were found 
in fraction 4, which contained 99% granulated mast cells and generated 24 mast cell 
colonies. However, fraction 3, which contained only 5% granulated mast cells, 
yielded 84 colonies. Thus it is apparent that mature mast cells cannot account for 
the majority of the colony forming potential found in the peritoneal cavity. Second, 
fraction 3 possesses a similar density to that observed for the mast cell-committed 
progenitor, which had a range of 1 .060- 1 .070 (Jarboe et al., 1989). Thus the cell 
fraction which yielded the greatest response to 3T3 FCM appears to resemble the 
committed progenitor found in the Nb-MLN. 
Density-dependent separation of peritoneal cells on day 14 of Nb infection 
gave results which contrasted to the separation of day 0 cells. Day 14 cells were 
separated into two fractions: those with density less than 1 .082 (fraction 1), and cells 
with density greater than 1 .082 (fraction 2). As expected, unseparated day 14 cells 
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showed no responsiveness to FCM. However, while the lower density fraction did 
not respond to FCM, day 14 peritoneal cells with a density greater than 1 .082 yielded 
40 mast cell colonies in response to 3T3 FCM. Fraction 1 contained 2% mast cells, 
and a majority of large blasts and macrophages, while fraction 2 contained 12% mast 
cells and many small blasts. The difference in the percentage mast cells for fraction 
2 of day 14 animals versus fraction 4 for naive animals, which have the same density, 
is not clear, but could be a result of the increased cell numbers present in the 
peritoneal cavity during Nb infection. The ability to generate mast cell colonies in 
response to 3T3 FCM seemed to segregate with the more dense cells in Nb infected 
animals. This suggests that some form of active suppression may be in effect to 
prevent mast cell progenitor proliferation in the peritoneal cavity during Nb infection. 
This data does not allow a determination of the ability of the peritoneal committed 
progenitor to respond, since cells of this density were pooled with the lower density 
cells. We therefore cannot determine if this cell is unable to respond or is no longer 
present in the peritoneum. 
Kanakura, et al. have found in the naive animal that mast cell progenitors 
segregate into three groups, as discussed above (Kanakura et al., 1988). Large-CFU­
Mast, which yielded the majority of mast cell proliferation, were found to possess a 
density less than 1 .077, similar our findings. However, this group also showed that 
the presence of granulated peritoneal mast cells could diminish the proliferative 
potential of L-CFU-Mast. This finding in the naive animal contrasts with our results 
obtained with Nb infected animals, where granulated mast cells could proliferate only 
in the absence of lower density cells. The lower density cells may be producing INF 
gamma or TGF6, which have both been shown to be immunosuppressive for mast 
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cells and their progenitors (Huff and Justus, 1988). 
Taken together these data indicate that the normal peritoneal cavity contains 
a mast cell progenitor that resembles the committed progenitor of the Nb-MLN, but 
this progenitor disappears from the peritoneum during Nb infection, perhaps due to 
trafficking to the MLN, or active inhibition of proliferation. 
V) SCF Expression by Human and Rat Placental Tissues 
Among the many tissues in which SCF expression has been detected are the 
murine placenta, ovaries, and testis (Matsui et al., 1990). This pattern of expression 
may explain the sterility associated with mutations at the Steel locus. In collaboration 
with Dr. Scott Kauma (Obstetrics and Gynecology, MCV-VCU), we attempted to 
determine the extent of SCF expression in human and rat placental tissues. Northern 
hybridization of total RNA extracted from several rat placental tissues at different 
time points during pregnancy showed the expression of a 6.5 kb transcript which 
hybridized with a SCF eDNA probe, which is similar to the published sizes of murine 
SCF transcripts (Anderson et al., 1990; Zsebo et al., 1990; Matsui et al., 1990). 
Expression of this band was observed in endometrial tissues and placenta, where it 
from day 15 to day 18. However, little expression was detected in day 15 or day 18  
decidua. Endometrial tissues differentiate into decidua late in  the menstrual cycle 
in preparation for egg implantation. Thus SCF expression appears to be limited to 
specific tissues involved in embryonic development. 
Initial experiments attempting to detect SCF expression in total RNA from 
human placenta were unfruitful, requiring the use of poly A+ RNA in Northern 
analysis. Hybridization of poly A+ human placental RNA resulted in detection of a 
6. 1 kb band; no band could be detected in total RNA. 
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These results indicate that SCF is expressed in the rat and human placenta, 
similar to the findings in the murine system. However, we have found that 
expression in the rat is restricted to specific uterine tissues. In the human system, 
SCF does not appear to be as highly expressed as the murine or rat models. The 
expression of SCF in placental tissues from mouse, rat, and man, coupled with the 
sterility associated with mutations at the Sf locus indicates a potentially important 
role for SCF in embryonic development. 
In summary, this work demonstrates the expression of a recently described 
growth factor, stem cell factor, in a myriad of tissues, including Schwann cells, mast 
cells, and fetal and maternal tissues during pregnancy. Since mutations which disrupt 
the expression of SCF and its receptor have been shown to result in deficiences in 
the hematopoietic and primordial germ cell lineages, and expression of SCF and c-kit 
has been detected in the nervous system, our results agree with the findings of other 
workers in the field. Beyond its already-described abilities as a mast cell growth 
factor, these results indicate that this growth factor-receptor complex may play an 
important, and until now undescribed, role in the development and repair of the 
peripheral nervous system. 
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Appendix A 
Human and Rat Stem cell Factor: 
5' Primer: 5' ATC ATA TGA AGA AGA CAC AAA CTT GG 
(Nucleotides 184-204) 
3' Primer: 5' ATG GAT CCT TAC ACT TCT TGA AAC TCT CTC TCT T 
(Nucleotides 1 005-980) 
Probe: 5' GTA GTG GCA TCT GAA ACT AGT GAT TGT GTG G 
(Nucleotides 534-676) 
Mouse Stem Cell Factor: 
5' Primer: 5' ATG ATA ACC CTC AAC TAT GTC GCC 
(Nucleotides 361-384) 
3' Primer: 5' CCT A TI ACT GCT ACT GCT GTC A TI CC 
(Nucleotides 788-763) 
Probe: 5' AGC TIG ACT ACT CTT CTG GAC AAG TIC TCA 
(Nucleotides 446-475) 
Rodent interleukin-3: 
5' Primer: 5' GTI CTT GCC AGC TCT ACC ACC A 
(Nucleotides 1380- 1402) 
3' Primer: 5' TGG GCC ATG AGG AAC A TI CAG 
(Nucleotides 3783-3764) 
Probe: 5' GCT CTG CCT GCT GTI TI A ACA TIC CAC GGT 
(Nucleotides 3724-3753) 
Human Actin: 
5' Primer: 5' CCA CGA AAC TAC CTT CAA CTC C 
(Nucleotides 822-844) 
3' Primer: 5' TCA TAC TCC TGC TIG CTG ATC C 
(Nucleotides 1045-1067) 
Probe: 5' GCA CCC AGC ACA ATG AAG ATC AAG ATC A TI 
(Nucleotides 960-989) 
Rodent Actin: 
5' Primer: 5' ATC T AC GAG GCC TAT GCT CTC C 
(Nucleotides 415-436) 
3' Primer: 5' TCT GCA TCC TGT CAG CAA TGC C 
(Nucleotides 844-823) 
Probe: 5' AGA GAA GCT GTG CT A TGT TGC TCT AGA CTT 
(Nucleotides 561-590) 
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Rat c-kit: 
5' Primer: 5' GGG A TT CAT CAA CAT err CC 
(Nucleotides 980-999) 
3' Primer: 5' CCT TCA GTT CTG ACA TT A GGG C 
(Nucleotides 1956- 1935) 
Probe: 5'  AAG ACG TGT CT A CAT CCG TGG ACT CCA TGT 
(Nucleotides 75 1-780) 
Human c-kit: 
5' Primer: 5' CAG err CAG AA T GGC A TT GT A 
(Nucleotides 3868-3888) 
3' Primer: 5' GGC T AC AGT CT A AAG GGT AAA 
(Nucleotides 4386-4366) 
Probe: 5' TCA GT A ACT TTG TCA AAC AGC ATC AAA TCC 
(Nucleotides 3878-3907) 
Human interleukin-3: 
Primer 1 :  5' CAA CTC CTG GTC CGC CCC GGA CTC (Nucleotides 40-64) 
Primer 2: 5' CAA CAG ACG ACT TTG AGC CTC (Nucleotides 437-458) 
Probe: 5' AA T AAC err CGA AGG CCA AAC CTG GAG GCA 
(Nucleotides 219-248) 
Human GM-CSF: 
Primer 1: 5'  TGA ACC TGA GTA GAG ACA CTG (Nucleotides 136- 156) 
Primer 2: 5' TCC CTC CAA GAT GAC CAT CCT (Nucleotides 509-529) 
Probe: 5' ACC ATG ATG GCC AGC CAC T AC AAG CAG CAC 
(Nucleotides 294-323) 
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Appendix B 
Table VIII 
Factors Unable to Support Committed Projl:enitor Development 
IL- l ( 1 ,5,20 U/ml) 
IL-2 ( 100 U/ml) 
IL-4 ( 100,200 U/ml) 
GM-CSF (50, 100,200 U /ml) 
G-CSF (50 U /ml) 
M-CSF ( lOX cone. L929-CM) 
NGF (5, 10,20,50, 100,500 ng/ml) 
EGF (0.5, 1 ug/ml) 
IFN-g ( 100 U/ml) 
IFN-a/b ( 100 U /ml) 
TNF ( 10 ng/ml) 
Fibronectin ( 1,4,20, 100 ug/ml) 
bFGF (5,25,50 ng/ml) 
TGFb ( 1,5, 10  ng/ml) 
P40 (5, 10, 100 u/ml) 
Mixture: 100 U/ml IL-2,1L-4,G-CSF,GM-CSF; lOX CM M-CSF 
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Figure 32 
RT-PCR for IL-3 expression. Total RNA extracted from (A) BALB/c 3T3 
fibroblasts or (B) WEHI-3 myelomonocytes was subjected to RT-PCR analysis using 
primers specific for the mouse IL-3 RNA sequences. Lane (C) is a control sample 
containing all reactants except RNA. PCR was carried out as described in Materials 
and Methods with an annealing temperature of 50°C for 30 cycles. Arrowhead 
indicates expected 470 base pair product. 
F==================== ===========-=- =·-=--�-==� 
A B c 
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Table IX 
Blinded Amgen Samples Used in Committed Progenitor Assay 
Sample Number of Mast Cell Identity 
Colonies ( ± SEM) 
1 16 ± 1.0 lx 3D-CM 
2 0 lx 3D-CM, No Serum 
3 43 ±9.0 lOx 3D-CM 
4 0 YM-5 Filtrate of #3 
5 0 cDMEM 
6 0 lOx cDMEM 
7 0 YM-5 Filtrate of #6 
15x 3D-CM 8 ±2.0 
Medium 0 
Vita 
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